Beyond the shared frailty model by Munda, Marco
Available at:
http://hdl.handle.net/2078.1/150625
[Downloaded 2019/04/19 at 11:11:35 ]
"Beyond the shared frailty model"
Munda, Marco
Abstract
This thesis deals with frailty modelling, a framework devised to analyse clustered
survival data. The main focus is on modelling the frailty term. The frailty term
captures the dependence of survival times within a cluster and the heterogeneity
between clusters. Typical is that the frailty term is treated as a random effect.
Different distributions have been proposed to model the frailty term. Contributions
of this thesis include a unified framework for fitting the frailty model with different
frailty distributions, a new diagnostic plot to evaluate the frailty distribution
assumption, a simulation study to assess robustness of regression inference
against frailty misspecification, and a method to test for decreasing cluster
heterogeneity in a new time-varying frailty model. Also presented is a first step
towards modelling spatial dependence in survival data by means of spatially
correlated frailties.
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1Introduction
1.1
Outline
In survival analysis, the outcome of interest (response variable) is a
time-to-event endpoint, also called survival endpoint, e.g. time to death
in cancer clinical trials. The central problem in the analysis of time-to-
event endpoints is the presence of censoring. In its most common form
(right censoring), censoring occurs when the follow-up is interrupted
prior to the event’s occurrence. In that case, only a lower boundary
is known for the event time. Section 1.2 provides a general, practical
overview of survival analysis. Topics covered include terminology, special
features of survival data, working assumptions, and standard methods
of analysis to deal with censored data (non-parametric Kaplan-Meier
survival curve, parametric Weibull regression, semi-parametric Cox re-
gression). Further details can be found in textbooks, e.g. Collett (2003).
Standard methods in survival analysis require independent event
times, given the covariate information. In practice, many studies in-
volve clusters. Examples of clusters include families, geographical areas,
centres participating in a clinical trial, etc. Within a cluster, data are
typically dependent. This thesis focuses on the frailty model, introduced
in Section 1.3, to account for the dependence in clustered survival data.
In the frailty model framework, the within-cluster association is taken
into account by means of a cluster-specific factor, the frailty term. Typ-
ical for this model is that the frailty term is treated as a random effect.
Random effects for survival data were first considered in Beard (1959)
and Vaupel et al. (1979) to improve the fit of mortality models at ad-
vanced ages. In these early papers, the frailty term acts at the individ-
ual level as an unobservable factor in the mortality model and indicates
that “frail” people have an increased risk of death. The distribution
of the individual-specific frailty term provides a way to model unob-
1
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served/unexplained variation in susceptibility to death (heterogeneity)
in the population.
Applications of the frailty model to clustered data were first dis-
cussed in Clayton (1978) for studies of familial aggregation of disease.
Due to, for example, genetic and environmental factors, susceptibility
to disease varies from family to family. Hence, variability in outcome
among relatives tends to be lower than variability in outcome between
non-relatives. In statistical terms, this translates into (i) unobserved
heterogeneity between families, and into (ii) association among observa-
tions from the same family. Frailty models with a cluster-specific frailty
term, also called shared frailty models, have been developed over the
last three decades to deal with this type of data.
For an introduction to the most important aspects of the frailty
model methodology, as well as an extensive list of references to major
papers and recent developments in the area, see Duchateau & Janssen
(2008) and Wienke (2010). Nice applications illustrating the usefulness
of the frailty model in practice include Michiels et al. (2005), Legrand
et al. (2006), and Rondeau et al. (2010).
This thesis is organised around three research themes of current inter-
est in frailty modelling. The content of each research theme is outlined
below.
Part I – The frailty distribution
Different distributions have been proposed to model the frailty term.
To mimic the normal random effect distribution from the linear mixed
model, the log-normal distribution can be used. Compared to the log-
normal, the gamma distribution has the advantage of mathematical
tractability; it is the most common distribution in practice. The inverse
Gaussian and the positive stable have proven useful to model alternative
dependence structures in the data. The power variance function distri-
bution contains the inverse Gaussian as a special case, as well as the
gamma and the positive stable as limiting cases. Therefore, the family
of power variance function distributions might be useful in a goodness-
of-fit context. The compound Poisson distribution has the particularity
of having a point mass at zero. The compound Poisson distribution
thus provides a way to model a cure fraction in the population. The
general characteristics of these frailty distributions are studied in de-
tail in Hougaard (2000, Chapter 7) and in Duchateau & Janssen (2008,
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Chapter 4). In the thesis appendix (Appendix 1), we collect their main
characteristics for ease of reference.
In practice, mainly the gamma and the log-normal distributions are
used to model the frailty term. The application of other frailty distri-
butions is hindered by the lack of software. To fill this gap, we have
developed the R library parfm, which stands for “parametric frailty
models”. To fit the frailty model in the parfm framework, it suffices
to be able to compute higher-order derivatives of the Laplace transform
of the frailty term. Currently, parfm supports the gamma, the inverse
Gaussian, the positive stable, and the log-normal frailty distributions.
Additional frailty distributions, including the power variance function
and the compound Poisson, may be added in the future. Chapter 2,
which extends the results published in Munda et al. (2012), outlines the
methodology of parfm.
Implicit in the frailty model approach to adjust for dependence in
clustered survival data is the assumption that the frailty term varies
randomly among clusters according to the specified frailty distribution.
For multicentre clinical trials, where the dependence is usually not of
direct interest (nuisance), we will argue that inference about the treat-
ment effect is robust against misspecification of the frailty distribution
(cf. Chapter 4). In contrast, the dependence is the interesting aspect
of some studies, e.g. genetic studies in twins (Hougaard et al., 1992)
or treatment outcome studies (Legrand et al., 2002, 2006). Typical for
such studies is that the dependence structure is dictated by the choice of
frailty distribution (Anderson et al., 1992; Hougaard, 1995). Research
on diagnostic techniques to assess the frailty distribution assumption is
sparse and such techniques are rarely used in practice. Chapter 3 in-
troduces a new diagnostic plot for the frailty distribution in the shared
frailty model. The content of this chapter is submitted for publication
(Munda & Legrand, 2014b).
Part II – Heterogeneity in multicentre trials
An important field of applications of frailty models concerns the analysis
of multicentre randomised clinical trials. In such a trial, patients who
meet the eligibility criteria are allocated at random to one of two (or
more) treatment groups and followed up for the endpoint of interest. In
a multicentre clinical trial, randomisation is usually stratified by centre,
and centres may be quite different from one another (differences in centre
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type, differences in specialty, differences in standard practice patterns,
differences in patient management, differences in catchment area, etc.).
Multicentre clinical trials are therefore subject to centre heterogeneity
(clustering). The shared frailty model then provides a convenient tool for
the analysis of multicentre clinical trials with a time-to-event endpoint.
The primary analysis of multicentre randomised clinical trials with
a time-to-event endpoint is commonly based on the Cox model. The
ICH E9 guidelines for the statistical analysis of clinical trials (Lewis,
1999) emphasise that “a method of adjustment” for centre heterogene-
ity should be used in the primary analysis. The cases of continuous
(Chu et al., 2011; Kahan & Morris, 2013) and binary (Kahan, 2014)
outcomes have been discussed previously. Mixed effects models can be
used advantageously in those settings. A similar investigation for time-
to-event outcomes is undertaken in Glidden & Vittinghoff (2004). The
latter paper is the starting point for further discussion in Chapter 4.
The central question addressed is whether the frailty approach is the
method to be recommended, considering the fact that frailty misspec-
ification is the rule, rather than the exception. The material of that
chapter is published in Munda & Legrand (2014a).
Beyond the main analysis of the treatment effect, multicentre clinical
trial data can be used to identify the centre characteristics or practice
patterns that lead to variation in outcome between centres. This type of
investigation, which primarily aims at improving the quality of patient
care, is termed “treatment outcome research”. The use of the frailty
model for treatment outcome research is illustrated in Legrand et al.
(2006). Power considerations, in terms of number of centres and num-
ber of patients per centre, are discussed in Duchateau et al. (2002). A
limitation of the frailty model in this context is that the frailty term is as-
sumed to be constant over time, implying that centre differences persist
throughout follow-up. Chapter 5 relaxes the time-constant heterogene-
ity assumption and proposes a new frailty model with a time-varying
frailty term. The time-varying frailty model can be used to determine
the extent of clustering over time. The particular application of Chap-
ter 5 concerns a cancer clinical trial on chronic myeloid leukemia where
heterogeneity between centres is shown to decrease after bone marrow
transplantation. The material of that chapter is submitted for publica-
tion (Munda et al., 2014).
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Part III – Spatial dependence
The dependence structure in the shared frailty model is in essence sim-
ilar to the compound symmetry structure in the linear mixed effects
model. That is, any two subjects within a cluster exhibit the same de-
gree of association. While this is appropriate for clinical trial patients
clustered within centres, other situations require more complex depen-
dence structures. The malaria study conducted around the Gilgel-Gibe
hydroelectric dam reservoir in Ethiopia (Yewhalaw et al., 2010, 2013) is
one such study. The risk of malaria is more similar for children living
in close proximity to each other than for children living far away from
each other. In other words, dependence is a function of the distance
between children (spatial dependence). The malaria data has already
been analysed to assess the effect of the Gilgel-Gibe dam on malaria
incidence by means of Poisson and frailty models using village as ran-
dom effect/frailty term (Yewhalaw et al., 2013; Getachew et al., 2013).
In Chapter 6, we provide new insights into these data by presenting a
first step towards modelling dependence as a function of distance using
a spatial frailty model. The work in this chapter is ongoing.
1.2
Elements of survival analysis
This section introduces some basic and general concepts in survival anal-
ysis used in the subsequent chapters. Further details can be found in
textbooks, e.g. Collett (2003) and Klein & Moeschberger (2003), among
many others. Section 1.3 introduces the concept of shared frailty, the
main topic of this thesis.
To set the scene, consider the survival data in Table 1.1. The data
show the time (in weeks) from remission to relapse, hereinafter referred
to as “survival time”, in two groups of acute leukemia patients initially
treated with corticosteroids. A total of 42 patients, in complete or partial
corticosteroid-induced remission, were randomly assigned at remission to
one of two maintenance therapies: 6-MP, an immunosuppressive drug, or
placebo. Patients were paired by remission status (complete or partial),
a fact that we ignore for the moment. Details on the study design can
be found in Gehan & Freireich (2011).
Chapter 1 6
Table 1.1: The remission duration data. The first two columns contain
the patient identification number and the pair identification number.
The third column gives the time (in weeks) from remission to relapse
(“survival time”) and the fourth column is the event indicator (1 =
relapse, 0 = censored). The fifth column specifies the treatment group
(1 = 6-MP, 0 = placebo).
id pair time status group
1 1 1 1 0
2 1 10 1 1
3 2 22 1 0
4 2 7 1 1
5 3 3 1 0
6 3 32 0 1
7 4 12 1 0
8 4 23 1 1
9 5 8 1 0
10 5 22 1 1
11 6 17 1 0
12 6 6 1 1
13 7 2 1 0
14 7 16 1 1
15 8 11 1 0
16 8 34 0 1
17 9 8 1 0
18 9 32 0 1
19 10 12 1 0
20 10 25 0 1
21 11 2 1 0
22 11 11 0 1
23 12 5 1 0
24 12 20 0 1
25 13 4 1 0
26 13 19 0 1
27 14 15 1 0
28 14 6 1 1
29 15 8 1 0
30 15 17 0 1
31 16 23 1 0
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32 16 35 0 1
33 17 5 1 0
34 17 6 1 1
35 18 11 1 0
36 18 13 1 1
37 19 4 1 0
38 19 9 0 1
39 20 1 1 0
40 20 6 0 1
41 21 8 1 0
42 21 10 0 1
1.2.1 Notations and terminology
The remission duration data is subject to right censoring. The survival
time random variable, i.e. time from randomisation (≈ time from re-
mission) to relapse is denoted by T . The censoring time, i.e. time from
randomisation to last contact in remission (study completion in this
case), is denoted by C. Therefore, the random variables that we observe
are Y = min(T,C) and ∆ = I(T ≤ C), i.e. the follow-up time and the
event (relapse from remission) indicator. The realisations of (Y,∆) for
the remission duration data are given in columns 3 and 4 of Table 1.1.
For example, patient 2 went out of remission at 10 weeks whereas obser-
vation 42 is censored at the same time. Though not directly observed,
interest lies in T , the actual survival time. Besides the probability den-
sity function f(·) and the cumulative distribution function F (·), common
ways of characterising T are:
• the survival function
S(t) = Pr(T > t)
giving the probability that a patient continues to be in remission
(“survives”) at time t;
• the hazard function
h(t) = lim
∆t→0
Pr(t ≤ T < t+ ∆t |T ≥ t)
∆t
giving the instantaneous rate at which relapses occur in time for
patients still in remission;
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• the cumulative hazard function
H(t) =
∫ t
0
h(v) dv
giving the total amount of risk accumulated from the start to the
present (t).
We have the following relationships between f(t), F (t), S(t), h(t),
and H(t):
S(t) = 1− F (t)
S(t) = −dfdt (t)
h(t) = f(t)
S(t)
S(t) = exp
(−H(t))
The density and survival functions of C will be denoted by g(·) and
G(·), respectively.
1.2.2 Censoring
Coping with censored data requires working assumptions about the
mechanism by which censoring occurs. A number of right censoring
mechanisms, as well as other types of data incompleteness (e.g., interval
censoring and truncation) are discussed in Lawless (2002, Chapter 2).
The random right censorship model outlined above for the remission du-
ration data (cf. Section 1.2.1) is adequate for most purposes. Further, it
is typically required that the censoring mechanism is independent and
non-informative. Under these conditions, a simple expression is obtained
for the likelihood (see Section 1.2.3 below).
Independent censoring
Independent censoring is the requirement that the hazard rate of an at-
risk subject coincides with the hazard rate in the surviving population,
i.e.
lim
∆t→0
Pr(t ≤ T < t+ ∆t |T ≥ t, C ≥ t)
∆t
= lim
∆t→0
Pr(t ≤ T < t+ ∆t |T ≥ t)
∆t
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This requirement essentially means that the uncensored subjects under
follow-up must be representative of the surviving population; a condi-
tion that is satisfied when censoring occurs independently of the survival
time (e.g., censoring due to calendar termination of the study). If there
are covariates, then the independent censoring assumption is made con-
ditional on the covariate information.
Non-informative censoring
If the censoring time distribution provides no information about the
survival time distribution, then the censoring mechanism is said to be
non-informative (for inference about the parameter(s) of interest).
1.2.3 Survival likelihood
With independent censoring, the joint distribution of T and C can be
factored into the product of the marginals. Therefore,
• (y, 1) contributes to the likelihood with the factor f(y)G(y);
• (y, 0) contributes to the likelihood with the factor S(y)g(y).
Further, if the censoring time distribution does not contain information
on the parameter(s) of the survival time distribution (non-informative
censoring), then g(y) and G(y) can be dropped from the above contri-
butions. In that case,
• the relevant information contained in an event data is that the
event occurred at the observed time;
• the relevant information contained in a censored data is that the
event time exceeds the censoring time.
Under these conditions, the survival likelihood for a sample of size
N is
L ∝
N∏
j=1
f(yj)δjS(yj)1−δj
=
N∏
j=1
h(yj)δjS(yj)
Chapter 1 10
Note: independence assumption
As L is factored into the product of the individual data contribu-
tions, independence between observations is also required.
1.2.4 Kaplan-Meier survival curve
The Kaplan-Meier estimator is a non-parametric estimator of S(t). Us-
ing non-parametric maximum likelihood estimation ideas, the Kaplan-
Meier estimator treats T as a discrete random variable with probability
mass at the observed event times only (Kalbfleisch & Prentice, 2002,
Section 1.4.1). Accordingly, the Kaplan-Meier survival curve is a (right
continuous) step function with jumps at the event times. When there is
no censoring, the Kaplan-Meier survival curve reduces to the empirical
survival function.
The survival function at y˜(j), the jth ordered event time, equals
S(y˜(j)) = Pr
(
T > y˜(j)
)
= Pr
(
T > y˜(j) |T > y˜(j−1)
)
S(y˜(j−1))
=
j∏
`=1
Pr
(
T > y˜(`) |T > y˜(`−1)
)
with y˜(0) := 0. Under the assumption of independent censoring, the n`
subjects at risk for the event at y˜(`) are representative of the surviving
population at y˜(`−1) (since T is treated as discrete); cf. Section 1.2.2.
Therefore, the conditional probability in the above formula can be esti-
mated by the proportion of survivors in the sample at risk, i.e. (n`−d`)/
n`. Hence, by piecewise constant interpolation, the Kaplan-Meier esti-
mator takes the form
Sˆ(t) =
∏
`: y˜(`)≤t
n` − d`
n`
For a fixed t, the Kaplan-Meier estimator Sˆ(t) has an asymptotic
normal distribution with mean S(t). The variance of Sˆ(t) can be esti-
mated by Greenwood’s formula,
V̂ar
(
Sˆ(t)
)
=
(
Sˆ(t)
)2 ∑
`: y˜(`)≤t
d`
n`(n` − d`)
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Figure 1.1: Kaplan-Meier survival curve in the remission duration data,
with number of subjects at risk.
A plot of the Kaplan-Meier survival curve in the remission duration
data is shown in Figure 1.1. The Kaplan-Meier survival curve crosses
the 50% line at 12 weeks, the non-parametric estimate of the median
survival time (i.e., the time beyond which the proportion in remission in
the study population equals 0.5). The value at the largest relapse time,
Sˆ(23) = 0.189, is the proportion in remission at the end of the study.
When different from zero (i.e. when the last observation is a censored
data), the Kaplan-Meier survival curve is undefined from that point on.
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1.2.5 Weibull proportional hazards model
A popular distribution to model the survival time T is the Weibull dis-
tribution, with the following characteristics:
f(t) = λρtρ−1 exp(−λtρ)
F (t) = 1− exp(−λtρ)
S(t) = exp(−λtρ)
h(t) = λρtρ−1
H(t) = λtρ
for ρ > 0 and λ > 0.
A number of Weibull hazard functions are plotted in Figure 1.2.
The Weibull hazard rate decreases, increases, or remains constant over
time for ρ < 1, ρ > 1, or ρ = 1 (exponential distribution), respectively.
That is, ρ is a shape parameter. In contrast, the parameter λ is a scale
parameter taking the form of a multiplier in the hazard function.
Note: R syntax
The relation with the parametrisation used by dweibull() in R is
as follows
shape = ρ and scale =
( 1
λ
)1/ρ
Weibull hazard rates with the same shape but different scales are
proportional. Covariates that act on the Weibull scale parameter thus
result in a proportional hazards model. The Weibull proportional haz-
ards model for the remission duration data can be written as
h(t) =
{
λρtρ−1 in the placebo group(
λ exp(β)
)
ρtρ−1 in the 6-MP group
with exp(β) a summary measure of the effect of 6-MP therapy on the
relapse hazard rate (the exponential transformation ensures positivity
without any parameter constraint).
By maximum likelihood estimation (cf. Section 1.2.3), we find ρˆ =
1.366 (se = 0.201), λˆ = 0.046 (se = 0.026) and βˆ = −1.731 (se = 0.413).
The fact that βˆ is significantly less than 0 (95% CI: [−2.540,−0.921])
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Figure 1.2: Weibull hazard functions.
indicates that 6-MP maintenance therapy reduces the risk of a relapse,
and hence prolongs the duration of remission, in the study population.
The estimated hazard ratio is exp(βˆ) = 0.177 (95% CI: [0.079, 0.398]).
1.2.6 Cox model
Like the Weibull proportional hazards model (cf. Section 1.2.5), the Cox
model specifies the way the explanatory variables act on the hazard rate,
but, in contrast to the Weibull model, lets the time dependency of the
hazard rate unspecified,
h(t) = h0(t) exp(x′β)
with h0(·) a non-specified baseline hazard function, x = (x1 . . . xp)′
the vector of explanatory variables, and β = (β1 . . . βp)′ the vector
of regression parameters. Owing to its semi-parametric nature, the Cox
model has become routine in survival analysis. A nice and concise review
can be found in Katz & Hauck (1993).
The ratio of the hazard functions for two subjects with different
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covariate information, say xj1 and xj2 , is
hj1(t)
hj2(t)
= exp
(
(xj1 − xj2)′β
)
A one-unit change in one of the explanatory variables, while all other
are kept fixed, results in a proportional change in the hazard function
(proportional hazards assumption). The parameter βk in the Cox model
is thus interpreted as a conditional log hazard ratio. In essence, the
proportionality assumption is the requirement that each βk be constant
over time.
As h0(·) is left unspecified, we cannot make use of the survival like-
lihood from Section 1.2.3 to fit the Cox model. An estimate βˆ of β can
be obtained by maximising a partial likelihood instead. Assuming no
ties in the event times, the partial likelihood of the Cox model is given
by (see, e.g., Klein & Moeschberger, 2003, Section 8.3)
Lp(β; Z) =
N∏
j=1
(
exp(x′jβ)∑
`∈R(yj) exp(x′`β)
)δj
with R(yj) the risk set at time yj containing all subjects still under
observation just prior to yj . The partial likelihood of the Cox model
can be derived as a profile likelihood obtained by maximising, for fixed
β, the survival likelihood with respect to the discretised version of the
baseline hazard function (Klein & Moeschberger, 2003, Section 8.3). In
the case of ties, approximations of the partial likelihood (e.g., Breslow,
Efron) can be used (Klein & Moeschberger, 2003, Section 8.4). Approx-
imate standard errors of the maximum partial likelihood estimates are
given by the square roots of the diagonal entries of the negative inverse
Hessian matrix of `p(·; Z) := log(Lp(·; Z)) evaluated at the maximum.
Even though Lp(·; Z) is not a genuine likelihood, it has been shown that
consistency and asymptotic normality properties for the estimator of β
are preserved (Gill, 1984).
In the remission duration data, we find (using the Breslow approxi-
mation to handle ties) exp(βˆ) = 0.221 (95% CI: [0.099, 0.493]).
1.3
Frailty model
In the remission duration data (Table 1.1), the response variable (time
from remission to relapse) is observed for matched pairs of patients.
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Because of the matching, there is likely to be dependence in the data.
Matched patients tend to be more alike than unmatched patients, thus
indicating positive association within pairs. This kind of data is referred
to as “clustered data”. In the remission duration data, clusters are of
size 2. Multicentre clinical trial data, where patients are clustered within
centres, typically involve larger and varying cluster sizes. The shared
frailty model has been introduced to cope with clustered survival data.
For the jth subject (j = 1, . . . , ni) of the ith cluster (i = 1, . . . , s),
the (shared) frailty model is defined as
hij(t) = h0(t)ui exp(x′ijβ)
where ui denotes the multiplicative effect of cluster i. Thus, ui represents
the deviation of cluster i from the overall baseline risk. In the frailty
model, the cluster effect is random. That is, the ui’s are treated as the
actual (unobserved) values of a random variable U , the frailty term, and
hij(·) is interpreted as a conditional hazard given U = ui.
The frailty term can be interpreted as an unobserved covariate com-
mon to, or shared by, individuals in a cluster. As U takes the same
value for each subject in a cluster, the frailty term generates (positive)
association between event times in a cluster. The frailty model is based
on a conditional independence assumption. Given the frailty and co-
variates, observations are assumed to be independent. That is, if the
common risk (frailty) term was known, observations would have been
independent.
Another way to look at the frailty model is in terms of heterogeneity.
Cluster heterogeneity, i.e. variation in susceptibility to the event from
cluster to cluster, reflects different levels of risk across clusters and is
modelled by the random variation of the frailty term. To put it dif-
ferently, the presence of cluster heterogeneity indicates the presence of
unknown risk factors varying from cluster to cluster. No cluster hetero-
geneity (U degenerated) implies independent data given the covariates,
and vice versa.
To model the frailty term, a distribution, called the frailty dis-
tribution, is postulated. In principle, any distribution on the posi-
tive half-line can play the role of the frailty distribution. To keep the
mathematics tractable though, distributions with simple Laplace trans-
forms are preferred. The Laplace transform of the frailty term, i.e.
L(x) = E( exp(−Ux)), characterises the frailty distribution uniquely
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(provided that it exists) and plays an important role in frailty modelling.
In the thesis appendix (Appendix 1), we describe, under the parametri-
sation that we shall use throughout the thesis†, the main characteristics
of six important frailty distributions: the gamma (Gam), the inverse
Gaussian (IG), the positive stable (PS), the log-normal (LN), the power
variance function (PVF), and the compound Poisson (CP). The thesis
appendix only collects useful formulas for ease of reference. The gen-
eral characteristics of these frailty distributions are studied in detail in
Hougaard (2000, Chapter 7) and in Duchateau & Janssen (2008, Chap-
ter 4). In practice, the gamma distribution is most often used to model
the frailty term.
The concept of shared frailty was introduced in Clayton (1978). Sug-
gestions for introductory reading on this topic are Liang et al. (1995)
and Hougaard (1995). A recent overview of frailty modelling is given
in Govindarajulu et al. (2011). The frailty model methodology is thor-
oughly presented in textbooks; see Hougaard (2000, Chapters 7–11),
Duchateau & Janssen (2008), and Wienke (2010).
The latent nature of the frailty term makes it more difficult to fit
frailty models. Inference for frailty models is discussed in Chapter 2. In
practice, the most common way to fit the (gamma) frailty model is by
means of coxph() in R (part of the survival library). For a detailed
description of the proper use of coxph() for frailty models, see Therneau
& Grambsch (2000, Chapter 9).
In the remission duration data, we find (using coxph() with the
gamma frailty distribution and the Breslow approximation to handle
ties) exp(βˆ) = 0.221 (95% CI: [0.099, 0.493]). In this case, the frailty
model produces the same result as the Cox model. This suggests that
the frailty term does not contribute to the model. Further indication is
provided by the estimated variance of the frailty term, θˆ = 4.77× 10−8,
which is virtually zero.
Note: hij(·) := h(· |xij , ui)
The notation hij(·) is used throughout the thesis as shorthand for
h(· |xij , ui), the conditional hazard for subject j in cluster i.
†The densities are already rescaled to ensure identifiability of the parameters in the
frailty model (Hougaard, 2000, page 221), similar to the zero-mean constraint for
the random effects in the linear mixed model.
Part I
The frailty distribution

2A unified framework for fitting the
frailty model with different frailty
distributions
There are at least three things that need to be put into consideration
when it comes to choosing a method of estimation to fit the frailty
model. The first one is a recurrent question in survival analysis: shall
we specify a parametric form for the baseline hazard (parametric ap-
proach) or shall we leave it unspecified (semi-parametric approach)? A
comparison of parametric and semi-parametric survival models can be
found in Nardi & Schemper (2003). This chapter focuses on the para-
metric approach. However, the results of this chapter are useful as well
in the implementation of the EM algorithm within the semi-parametric
setting. The second point concerns the choice of the frailty distribution.
In this chapter, we show that many frailty distributions, including those
introduced in the thesis appendix (Appendix 1), can be handled in a
uniform way. Third, from a purely pragmatic point of view, software
availability weighs in the balance. The method of this chapter, based
on the maximum likelihood principle, only requires a numerical optimi-
sation procedure. We have implemented the method in the R library
parfm.
In Section 2.1, different likelihoods for frailty models are defined.
The parametric frailty model is fitted based on the marginal likelihood.
In Section 2.2, it is shown that a generic form of the marginal likelihood
can be written by means of the derivatives of the Laplace transform of
the frailty term. The parametric approach is outlined in Section 2.3. Ex-
plicit derivative formulas are given in Section 2.4. Section 2.5 illustrates
the use of parfm.
For a detailed review of model estimation techniques in the semi-
parametric setting, see Cortiñas Abrahantes et al. (2007). An overview
of the available software in that setting is provided in Hirsch & Wienke
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(2012).
The content of this chapter extends the results published in Munda
et al. (2012).
2.1
Conditional, complete data, and marginal likelihoods
Observed data
Let Zi be the vector that contains the relevant information from cluster i
(i = 1, . . . , s), i.e.
Zi =
{
(yij , δij ,xij) | j = 1, . . . , ni
}
where yij is the time to event or censoring, whichever comes first, δij
indicates whether an observation corresponds to an event (δij = 1) or is
censored (δij = 0), and xij is the vector with the measured covariates
for subject j of cluster i. The frailty of cluster i, ui, is not observed.
Conditional likelihood
Given the latent data information u = (u1 . . . us)′ and the covariate in-
formation, event times are treated as independent (conditional indepen-
dence assumption). The conditional likelihood of the data Z = {Zi | i =
1, . . . , s} is thus written as (cf. Section 1.2.3)
Lcond(h0(·),β; Z |u)
=
s∏
i=1
ni∏
j=1
(
hij(yij)
)δij
Sij(yij)
=
s∏
i=1
ni∏
j=1
(
h0(yij)ui exp(x′ijβ)
)δij exp (−H0(yij)ui exp(x′ijβ))
Complete data likelihood
The complete data likelihood treats the frailties as if they were observed.
It therefore follows from the joint likelihood of Z and u,
Lfull(h0(·),β,θ; Z,u) = Lcond(h0(·),β; Z |u)× f(u)
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with f(·) := f(·; θ) the frailty density with parameter vector θ. If the
ui’s are independent and identically distributed, which we assume in the
following, then f(u) can be written as ∏si=1 f(ui).
Marginal likelihood
To arrive at a likelihood not depending on the unobservables, the ui’s
have to be integrated out to form the marginal likelihood (also called
the observed likelihood),
Lmarg(h0(·),β,θ; Z) =
∫ ∞
0
· · ·
∫ ∞
0
Lfull(h0(·),β,θ; Z,u) du1 · · · dus
(2.1)
2.2
Generic form of the marginal likelihood
It is convenient to rewrite the marginal likelihood (2.1) in a generic form
in terms of L(·), the Laplace transform of the frailty term U , i.e. in terms
of
L(x) = E
(
exp(−Ux)
)
=
∫ ∞
0
exp(−ux)f(u) du
Let Di =
∑ni
j=1 δij denote the number of events in cluster i, and
L(q)(·) be the qth derivative of L(·), q ≥ 0, i.e.
L(q)(x) = (−1)q
∫ ∞
0
uq exp(−ux)f(u) du
We have
Lmarg(h0(·),β,θ; Z) =
s∏
i=1
 ni∏
j=1
(
h0(yij) exp(x′ijβ)
)δij
× (−1)DiL(Di)
 ni∑
j=1
H0(yij) exp(x′ijβ)

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Taking the logarithm, the marginal log-likelihood is obtained
`marg(h0(·),β,θ; Z) =
s∑
i=1
 ni∑
j=1
δij
(
log
(
h0(yij)
)
+ x′ijβ
)
+ log
(−1)DiL(Di)
 ni∑
j=1
H0(yij) exp(x′ijβ)

2.3
Parametric framework
In the parametric framework, we adopt a baseline hazard function h0(·)
that is completely specified, except for a number of unknown parameters
that are estimated together with β and θ. Common choices for h0(·)
are collected in Table 2.1. This results in a fully parametric marginal
log-likelihood that can be maximised by means of an optimisation rou-
tine (e.g., a Newton-type algorithm). This task is most easily done
when L(q)(·) exists in closed form. This is the case for the gamma,
the inverse Gaussian, the positive stable, the power variance function,
and the compound Poisson frailty distributions (cf. Sections 2.4.1–2.4.5).
The Laplace transform of a log-normal frailty term, on the other hand,
does not exist in closed form. In that case, we can approximate the
marginal log-likelihood by means of the Laplace approximation of inte-
grals (cf. Section 2.4.6).
2.4
Derivative formulas
2.4.1 Gamma frailties
If U ∼ Gam(θ), then the Laplace transform is
L(x) = (1 + θx)− 1/θ, x ≥ 0
and, for q ≥ 1, it is easy to see that
L(q)(x) = (−1)q (1 + θx)−q
q−1∏
`=0
(1 + `θ)
L(x)
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Table 2.1: Parametric baseline hazard and cumulative baseline hazard
functions for selected event time distributions.
distribution param. h0(t) H0(t)
exponential λ > 0 λ λt
Weibull λ > 0 λρtρ−1 λtρ
ρ > 0
Gompertz λ > 0 λ exp(γt) λγ (exp(γt)− 1)γ > 0
log-logistic α ∈ R exp(α)κt
κ−1
1 + exp(α)tκ
log(1 + exp(α)tκ)
κ > 0
log-normal† µ ∈ R φ(z(t; µ, σ))
σt[1− Φ(z(t; µ, σ))] − log [1− Φ(z(t; µ, σ))]σ > 0
† z(t; µ, σ) := (log(t)− µ)/σ; φ(·) and Φ(·) denote the density and the cumulative
distribution functions of a standard normal random variable.
2.4.2 Inverse Gaussian frailties
If U ∼ IG(θ), then the Laplace transform is
L(x) = exp
{1
θ
(
1−√1 + 2θx
)}
, x ≥ 0
and, for q ≥ 1, we have (Munda et al., 2012)
L(q)(x) = (−1)q (2θx+ 1)− q/2
Kq−(1/2)
(√
2θ−1(x+ 1/2θ)
)
K1/2
(√
2θ−1(x+ 1/2θ)
) L(x)
with Kγ(·) the modified Bessel function of the second kind,
Kγ(ω) =
1
2
∫ ∞
0
tγ−1 exp
{
−ω2
(
t+ 1
t
)}
dt, γ ∈ R, ω > 0
Alternatively, as IG(θ) = PVF(1, θ, 1/2) (cf. Section 1.5 of the thesis
appendix), the formula of L(q)(x) from Section 2.4.4 can be used.
2.4.3 Positive stable frailties
If U ∼ PS(θ), then the Laplace transform is
L(x) = exp
(
−x1−θ
)
, x ≥ 0
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and, for q ≥ 1, it is found in Wang et al. (1995) that (cf. Lemma 3.1 in
that paper, which we write under a different parametrisation)
L(q)(x) = (−1)q
(
(1− θ)x−θ
)q q−1∑
`=0
Ωq,q−`(θ) (1− θ)−` x−`(1−θ)
L(x)
where the Ωq,m(θ)’s are polynomials of degree q−m in θ given recursively
by (cf. Appendix 2.A)
Ωq,m(θ) =

Γ
(
q − (1− θ))
Γ(θ) if m = 1
Ωq−1,m−1(θ)
+ Ωq−1,m(θ)
[
(q − 1)−m(1− θ)] if m = 2, . . . , q − 1
1 if m = q
2.4.4 Power variance function frailties
If U ∼ PVF(µ, θ, ν), then the Laplace transform is
L(x) = exp
{
ν
θ(1− ν)
[
1−
(
1 + θµx
ν
)1−ν]}
, x ≥ 0
and, for q ≥ 1, it is found in Hougaard (2000, Section A.3.4) that
L(q)(x) = (−1)q
[ q∑
`=1
Ωq,`(ν)µ`(1−ν)
(
ν
θ
)`ν ( ν
θµ
+ x
)`(1−ν)−q]
L(x)
where the Ωq,m(ν)’s are the same polynomials as above, evaluated at ν.
2.4.5 Compound Poisson frailties†
If U ∼ CP(µ, θ, ν), then the Laplace transform has the same analytical
form as for the PVF distribution (cf. Section 1.6 of the thesis appendix);
therefore so are the derivatives.
†We mean the compound Poisson distribution generated by gamma random variables.
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2.4.6 Log-normal frailties
If U ∼ LN(θ), then the Laplace transform does not exist in closed form.
Consequently
L(q)(x) = (−1)q
∫ ∞
0
uq exp(−ux)f(u) du
= (−1)q 1√
2piθ
∫ ∞
0
uq exp(−ux) 1
u
exp
(
− 12θ
(
log(u)
)2)
du
needs to be approximated (x ≥ 0). By using the change of variable
w = log(u), we have
L(q)(x) = (−1)q 1√
2piθ
∫ ∞
−∞
(
exp(w)
)q
exp
(
− exp(w)x
)
exp
(
−w
2
2θ
)
dw
= (−1)q 1√
2piθ
∫ ∞
−∞
exp
{
qw − exp(w)x− w
2
2θ
}
dw
We now show how to approximate this by means of the Laplace approx-
imation of integrals.
Let
g(w; x, θ) := −qw + exp(w)x+ w
2
2θ
g(1)(w; x, θ) := dgdw (w; x, θ) = −q + exp(w)x+
w
θ
g(2)(w; x, θ) := d
2g
dw2 (w; x, θ) = exp(w)x+
1
θ
> 0
The approximation consists of replacing g(·) by the first three terms
of its Taylor series expansion around some w˜,
g(w; x, θ) ≈ g(w˜; x, θ) + (w − w˜)g(1)(w˜; x, θ) + (w − w˜)
2
2 g
(2)(w˜; x, θ)
The value of w˜ is chosen such that g(1)(w˜; x, θ) = 0, so that L(q)(x)
can be approximated by
L(q)(x) ≈ (−1)q 1√
2piθ
exp {−g(w˜; x, θ)}
×
∫ ∞
−∞
exp
{
−(w − w˜)
2
2 g
(2)(w˜; x, θ)
}
dw
= (−1)q 1√
θ
exp
{
−g(w˜; x, θ)
} [
g(2)(w˜; x, θ)
]−1/2
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where the last line follows by recognising the kernel of a normal density
with mean w˜ and variance 1/g(2)(w˜; x, θ). This is known as the Laplace
approximation. The underlying idea is that the main contribution to
the integral comes from where g(·) is close to its minimum. We refer to
Goutis & Casella (1999) for further motivation and explanation of this
kind of approximation.
Note: prediction of the frailty term
The explicit formulas for L(q)(·) are also useful to predict the value
taken by the frailty term in a particular cluster. Indeed, the condi-
tional expectation of the frailty term, given the observed data from
cluster i and the parameters, can be written as
E
(
U | Zi; h0(·),β,θ
)
=
E
(
UDi+1 exp
(
−U∑nij=1H0(yij) exp(x′ijβ)))
E
(
UDi exp
(
−U∑nij=1H0(yij) exp(x′ijβ)))
= −
L(Di+1)
(∑ni
j=1H0(yij) exp(x′ijβ)
)
L(Di)
(∑ni
j=1H0(yij) exp(x′ijβ)
)
which follows from applying Bayes’ formula to f(u | Zi; h0(·),β,θ).
In particular, predictions of the frailties are needed in the E-step of
the EM algorithm (Nielsen et al., 1992).
The EM algorithm makes use of the complete data likelihood (cf. Section 2.1)
to fit the frailty model in the semi-parametric setting. The algorithm iterates
between an expectation step (or E-step) and a maximisation step (or M-step). In
the E-step, the unobserved frailties are replaced by their conditional expectations
given the observed data and the current parameter estimates. In the M-step,
new parameter estimates are found by maximising the complete data likelihood,
using the conditional expectations as offset terms.
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2.5
parfm†
The R function parfm(), part of the parfm library, builds the marginal
log-likelihood and calls optim(), part of the stats library, to perform
the optimisation. The basic usage of parfm() (version 2.5.6) is as fol-
lows:
Usage
parfm(formula, cluster, dist, frailty, data)
Arguments
formula a survival formula object
cluster character string indicating the cluster variable
dist character string indicating the baseline event time
distribution; one of "exponential", "weibull",
"gompertz", "lognormal", "loglogistic"
frailty character string indicating the frailty distribution;
one of "gamma", "ingau", "possta", "lognormal"
data data frame containing the variables named in "formula"
and "cluster"
To illustrate parfm, we consider a litter-matched experiment studying
the effect of a drug on the time until the appearance of a tumour in
rats (Mantel et al., 1977). Three (female) rats were chosen from each of
50 litters and followed for tumour incidence. Death from other causes
was considered as a censoring event (73%). In each litter, one rat was
selected at random and given the drug while the other two rats serve as
controls. In R, the data can be loaded using
> data(rats, package="survival")
> rats$time <− rats$time * 0.0328549 # days to months
> head(rats, n=10)
litter rx time status
1 1 1 3.318345 0
2 1 0 1.609890 1
3 1 0 3.416910 0
4 2 1 3.416910 0
5 2 0 3.351200 0
6 2 0 3.416910 0
7 3 1 3.416910 0
8 3 0 3.416910 0
9 3 0 3.416910 0
10 4 1 2.529827 0
†Implementation of parfm is joint work with Federico Rotolo.
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Below are the results of running parfm() with different frailty distri-
butions on the rats data, using the Weibull distribution to model the
baseline hazard.
Gamma frailties
> parfm(formula=Surv(time, status) ~ rx,
+ cluster="litter", dist="weibull", frailty="gamma",
+ data=rats)
Frailty distribution: gamma
Baseline hazard distribution: Weibull
Loglikelihood: −104.846
ESTIMATE SE p−val
theta 0.489 0.469
rho 3.929 0.569
lambda 0.002 0.002
rx 0.907 0.322 0.005 **
−−−
Signif. codes: 0 ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1 ’ ’ 1
Inverse Gaussian frailties
> parfm(formula=Surv(time, status) ~ rx,
+ cluster="litter", dist="weibull", frailty="ingau",
+ data=rats)
Frailty distribution: inverse Gaussian
Baseline hazard distribution: Weibull
Loglikelihood: −104.916
ESTIMATE SE p−val
theta 0.541 0.647
rho 3.931 0.572
lambda 0.002 0.002
rx 0.911 0.323 0.005 **
−−−
Signif. codes: 0 ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1 ’ ’ 1
Positive stable frailties
> # ‘iniFpar=’ sets the initial value of the frailty parameter (nu)
> parfm(formula=Surv(time, status) ~ rx,
+ cluster="litter", dist="weibull", frailty="possta",
+ data=rats, iniFpar=0.4)
Frailty distribution: positive stable
Baseline hazard distribution: Weibull
Loglikelihood: −104.947
ESTIMATE SE p−val
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nu 0.094 0.095
rho 4.103 0.627
lambda 0.002 0.001
rx 0.944 0.327 0.004 **
−−−
Signif. codes: 0 ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1 ’ ’ 1
Log-normal frailties
> parfm(formula=Surv(time, status) ~ rx,
+ cluster="litter", dist="weibull", frailty="lognormal",
+ data=rats)
Frailty distribution: lognormal
Baseline hazard distribution: Weibull
Loglikelihood: −104.599
ESTIMATE SE p−val
sigma2 0.575 0.489
rho 3.963 0.576
lambda 0.002 0.001
rx 0.916 0.325 0.005 **
−−−
Signif. codes: 0 ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’ 0.1 ’ ’ 1
All models lead to a significant effect of the drug. Additionally,
the treatment effect appears not to depend on the frailty distribution
assumption, anticipating the properties of robustness discussed in Chap-
ter 4.
In Klein & Moeschberger (2003, Section 13.3, Example 1.13) the re-
sults are given for the semi-parametric gamma frailty model fitted with
the EM algorithm: βˆ = 0.904 (se = 0.323) and θˆ = 0.472 (se = 0.462).
These results are very close to the results obtained for the Weibull
gamma frailty model fitted with parfm.
Alternatively, the Weibull gamma frailty model can be fitted by
means of the frailtypack library (Rondeau et al., 2012):
frailtypack fit
> library(frailtypack)
> frailtyPenal(Surv(time, status) ~ rx + cluster(litter),
+ Frailty=TRUE, hazard="Weibull", data=rats)
Be patient. The program is computing ...
The program took 0.77 seconds
Call:
frailtyPenal(formula = Surv(time, status) ~ rx + cluster(litter),
data = rats, Frailty = TRUE, hazard = "Weibull")
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Shared Gamma Frailty model parameter estimates
using a Parametrical approach for the hazard function
coef exp(coef) SE coef (H) z p
rx 0.90751 2.47814 0.322339 2.81539 0.0048718
Frailty parameter, Theta: 0.488854 (SE (H): 0.469033 )
marginal log−likelihood = −241.47
AIC = Aikaike information Criterion = 1.63648
The expression of the Aikaike Criterion is:
’AIC = (1/n)[np − l(.)]’
Scale for the weibull hazard function is : 140.91
Shape for the weibull hazard function is : 3.93
The expression of the Weibull hazard function is:
’lambda(t) = (shape.(t^(shape−1)))/(scale^shape)’
The expression of the Weibull survival function is:
’S(t) = exp[− (t/scale)^shape]’
n= 150
n events= 40 n groups= 50
number of iterations: 12
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Appendix 2.A
The Ωq,m(·)’s polynomials
The Ωq,m(·)’s that appear in L(q)(·) for the positive stable, the power
variance function, and the compound Poisson frailty distributions are
polynomials of degree q −m in α given recursively by
Ωq,m(α) =

Γ
(
q − (1− α))
Γ(α) if m = 1
Ωq−1,m−1(α)
+ Ωq−1,m(α)
[
(q − 1)−m(1− α)] if m = 2, . . . , q − 1
1 if m = q
for α ∈ (0, 1).
The first few polynomials are
m = 1 m = 2 m = 3 m = 4

q = 1 1
q = 2 α 1
q = 3 α(α+ 1) 3α 1
q = 4 α(α+ 1)(α+ 2) 7α2 + 4α 6α 1
An R function to calculate the Ωq,m(α)’s for q = 1, . . . , Q is
Omega <− function(Q, alpha)
{ # Q = order of the derivative > 0, alpha in (0, 1)
Omega <− matrix(NA, nrow=Q, ncol=Q, dimnames=list(q=1:Q, m=1:Q))
diag(Omega) <− 1
if(Q < 2)
return(Omega)
Omega[q=2:Q, m=1] <− cumprod(alpha + 0:(Q − 2))
if(Q < 3)
return(Omega)
for(m in 2:(Q − 1))
for(q in (m + 1):Q)
Omega[q, m] <− Omega[q − 1, m − 1] +
Omega[q − 1, m] * ((q − 1) − m * (1 − alpha))
return(Omega)
}
For example,
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> Omega(Q=4, alpha=0.1)
m
q 1 2 3 4
1 1.000 NA NA NA
2 0.100 1.00 NA NA
3 0.110 0.30 1.0 NA
4 0.231 0.47 0.6 1
Appendix 2.B
Derivative formulas in R
Gamma frailties
Lq_Gam <− function(q, theta, x)
{ # q >= 0, theta > 0, x >= 0
if(q == 0){
(1 + theta * x)^(−1 / theta)
} else{
(−1)^q * (1 + theta * x)^(−q) * prod(1 + 0:(q − 1) * theta) *
Lq_Gam(q=0, theta=theta, x=x)
}
}
Inverse Gaussian frailties
Lq_IG <− function(q, theta, x)
{ # q >= 0, theta > 0, x >= 0
if(q == 0){
exp((1 − sqrt(1 + 2 * theta * x)) / theta)
} else{
z <− theta^(−0.5) * sqrt(2 * x + 1 / theta)
(−1)^q * (2 * theta * x + 1)^(−q / 2) *
besselK(x=z, nu=q − 0.5) / (sqrt(0.5 * pi / z) * exp(−z)) *
Lq_IG(q=0, theta=theta, x=x)
}
}
Positive stable frailties
Lq_PS <− function(q, theta, Omega, x)
{ # q >= 0, theta in (0, 1), x >= 0
if(q == 0){
exp(−x^(1 − theta))
} else{
Sum <− 0
for(l in 0:(q − 1)){
Sum <− Sum +
Omega[q, q − l] * (1 − theta)^(−l) * x^(−l * (1 − theta))
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}
(−1)^q * ((1 − theta) * x^(−theta))^q * Sum *
Lq_PS(q=0, theta=theta, x=x)
}
}
Power variance function & compound Poisson frailties
Lq_PVF <− function(q, mu, theta, nu, Omega, x)
{ # q >= 0, mu > 0, theta > 0, nu in (0, 1) (PVF) or nu > 1 (CP),
# x >= 0
if(q == 0){
exp(nu / (theta * (1 − nu)) *
(1 − (1 + theta * mu * x / nu)^(1 − nu)))
} else{
Sum <− 0
for(l in 1:q){
Sum <− Sum +
Omega[q, l] * mu^(l * (1 − nu)) * (nu / theta)^(l * nu) *
(nu / (theta * mu) + x)^(l * (1 − nu) − q)
}
(−1)^q * Sum * Lq_PVF(q=0, mu=mu, theta=theta, nu=nu, x=x)
}
}
Log-normal frailties
Lq_LN <− function(q, theta, x)
{ # q >= 0, theta > 0, x >= 0
g <− function(w, q, x, theta)
−q * w + exp(w) * x + 0.5 * w^2 / theta
options(warn=−1)
wTilde <− nlm(f=g, p=0, q=q, theta=theta, x=x)$estimate
options(warn=0)
(−1)^q * theta^(−0.5) * exp(−g(w=wTilde, q=q, x=x, theta=theta)) *
(exp(wTilde) * x + theta^(−1))^(−0.5)
}

3A diagnostic plot for the frailty
distribution in the shared frailty model
When modelling dependence between event times, not only the degree
of global dependence is of interest, but also the way the local (at a
given time) dependence changes over time, i.e. the dependence structure.
In particular, the times at which the dependence is high often receive
special attention (see, e.g., Nan et al., 2006).
In the frailty model framework, the dependence structure is dic-
tated by the frailty distribution (Anderson et al., 1992; Hougaard, 1995).
Hence, the frailty distribution needs to be carefully chosen to correctly
model the dependence structure in the data. As the frailties are un-
observed, though, specifying the frailty distribution is a difficult issue.
This chapter introduces a new diagnostic plot to guide the choice of the
frailty distribution.
Section 3.1 provides references to key papers in the area and out-
lines a general diagnostic framework based on dependence measures. In
Section 3.2, we review common ways to measure dependence in survival
data and we discuss the patterns of dependence induced by different
frailty distributions. From the discussion of Section 3.2, it will become
clear that the probability mass that a frailty distribution puts in the
tails is a key feature as it drives the dependence structure. To cap-
ture the behaviour in the tails, the proposed diagnostic plot is based on
the quantile dependence function. Quantile dependence is introduced
in Section 3.3 where we explain how to obtain the model-based and the
non-parametric estimates that are used to construct the diagnostic plot.
The method is illustrated in Section 3.4 and is assessed with simulations
in Section 3.5. Concluding remarks are given in Section 3.6.
The content of this chapter is submitted for publication (Munda &
Legrand, 2014b).
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3.1
Introduction
As a matter of software availability, the gamma distribution is often
used in practice to model the frailty term. Diagnostic checks specific to
the gamma frailty distribution include Shih & Louis (1995), Cui & Sun
(2004), and Geerdens et al. (2013). Only a few diagnostic procedures are
available for other frailty distributions. The graphical tool developed in
Economou & Caroni (2008) is valid if, for all t, the distribution of the
frailty term among the “surviving clusters” at time t belongs to the same
family as the original frailty distribution (closure property). In Oakes
(1989), the cross ratio function, a measure of bivariate dependence, is
used as a diagnostic tool. The method can in principle be used with any
frailty distribution, but does not explicitly account for censoring. Some
technical improvements of the method are proposed in Viswanathan &
Manatunga (2001) and in Chen & Bandeen-Roche (2005). Another,
more computationally demanding, diagnostic tool based on the cross
ratio function is studied in Glidden (2007).
In the last four papers cited above, the basic idea is that although
frailties are unobservable, the dependence structure that they impose on
the data can be observed. Further, the dependence structure is dictated
by the frailty distribution (Anderson et al., 1992; Hougaard, 1995). It fol-
lows that a graphical comparison of the observed dependence structure
with selected model-based structures can be used to reveal the frailty
distribution that best describes the pattern of dependence in the data.
That is, the problem of assessing the frailty distribution assumption can
be linked to the problem of measuring dependence in clustered survival
data. Common ways to measure dependence in clustered survival data
are reviewed in the next section.
3.2
Dependence in bivariate survival data
Dependence measures have been developed mainly for bivariate data. In
this section, we review a number of coefficients that evaluate dependence
between two event times, (T1, T2).
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3.2.1 Overall dependence
Kendall’s τ is a rank-based dependence coefficient which ranges from
−1 to 1, with τ = 0 under independence. To define Kendall’s τ , we
need an independent copy (i.e. with the same distribution) of (T1, T2),
say (T ′1, T ′2). Kendall’s τ is the probability that (T1, T2) and (T ′1, T ′2) are
concordant minus the probability that this pair is discordant,
τ = Pr
(
(T1 − T ′1)(T2 − T ′2) > 0
)
− Pr
(
(T1 − T ′1)(T2 − T ′2) < 0
)
Thus, Kendall’s τ expresses the probability that the order of the first
coordinates is the same as the order of the second coordinates (“con-
cordance”, i.e. large values tend to occur with large values and small
values tend to occur with small values) minus the probability that the
order differs between the coordinates (“discordance”). Kendall’s τ is
scale-invariant, i.e. it remains unchanged under monotonic transforma-
tions of the random variables. It is worth noting that interpretation of
Kendall’s τ requires a pair of clusters and that observations within a
cluster must have an ordering ((T1 − T ′1)(T2 − T ′2) is not the same as
(T1 − T ′2)(T2 − T ′1)).
An alternative to Kendall’s τ , which can be interpreted with one
cluster only, is given by the median concordance coefficient, also known
as Blomqvist’s β,
β = Pr
(
(T1 − t˜1)(T2 − t˜2) > 0
)
− Pr
(
(T1 − t˜1)(T2 − t˜2) < 0
)
with t˜1 and t˜2 the medians of T1 and T2. Like Kendall’s τ , Blomqvist’s
β lies between −1 and 1, equals 0 under independence, and is invariant
under strictly increasing transformations of T1 and T2. Blomqvist’s β
often provides an accurate approximation to Kendall’s τ (Nelsen, 2006,
Section 5.1.4).
In the frailty model framework, dependence within a cluster is gen-
erated by the frailty term. Kendall’s τ and Blomqvist’s β can be written
in terms of the Laplace transform of the frailty term as (Hougaard, 2000,
Section 7.2.5)
τ = 4
∫ ∞
0
xL(x)L(2)(x) dx− 1
with L(2)(x) the second derivative of L(x) = E( exp(−Ux)), and
β = 4L{2L−1(1/2)}− 1
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Appendix 3.A provides explicit forms of τ and β for a number of
frailty distributions.
Note: τ = 0 and β = 0 do not imply independence
Kendall’s τ and Blomqvist’s β only capture monotonic association.
Under independence we have τ = 0 and β = 0, but τ = 0 and β = 0
do not imply independence in general.
Counterexample
Let X and Y be two continuous random variables with copula
C(u, v) = uv + θu(u− 1)(2u− 1)v(v − 1)(2v − 1)
for some parameter θ. In order for C(·, ·) to be 2-increasing (and
hence a copula; cf. Nelsen (2006, Definition 2.2.2, page 10)), we
restrict θ ∈ [−9, 9(√3− 1)]. Independence between X and Y corre-
sponds to θ = 0.
On the one hand, Kendall’s τ between X and Y is (Nelsen, 2006,
Theorem 5.1.3, page 161)
τ = 4
∫ 1
0
∫ 1
0
C(u, v) ∂
2C
∂u∂v
(u, v) dudv − 1 = 0
On the other hand, Blomqvist’s β between X and Y is (Nelsen,
2006, Section 5.1.4, Formula 5.1.27)
β = 4C
(1
2 ,
1
2
)
− 1 = 0
That is, τ = 0 and β = 0 even though θ 6= 0.
3.2.2 Local dependence
On average, frail subjects (those with a large value of U) experience
the event first. This selection process, to a large extent governed by
the frailty distribution, leads to changes in the dependence structure
over time. Kendall’s τ and Blomqvist’s β are overall measures of depen-
dence. Therefore, Kendall’s τ and Blomqvist’s β cannot detect changes
in the dependence structure over time. To address this question, a local
measure (i.e., as a function of time) is needed.
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The cross ratio function is a local measure of dependence defined as
(Clayton, 1978)
ζ(t1, t2) =
h1(t1 |T2 = t2)
h1(t1 |T2 > t2)
Thus, ζ(t1, t2) compares the hazard rate of member 1 at time t1 given
that member 2 failed at time t2 to the hazard rate of member 1 at t1
given that member 2 survived beyond t2. Unity indicates no association.
In the frailty model framework, ζ(t1, t2) depends on t1 and t2 only
through the joint survival function,
ζ(t1, t2) = ζ?
(
S(t1, t2)
)
where ζ?(·) determines the frailty distribution uniquely, up to a scale
factor (Oakes, 1989). Explicit forms of ζ?(·) are given in Appendix 3.A.
For the gamma frailty distribution, ζ?(·) is a constant. For both the
inverse Gaussian and the positive stable frailty distributions, ζ?(v) de-
creases to 1 as v → 0.
The cross ratio as a diagnostic tool
The diagnostic tool proposed in Oakes (1989) compares graphically a
non-parametric (model-free) estimate of the cross ratio to model-based
estimates. In particular, substantial deviation of the model-free estimate
from the constant line provides evidence against the gamma frailty dis-
tribution.
Model-based estimates of the cross ratio follow from estimates of
the frailty parameter obtained by fitting the frailty model with different
frailty distributions (cf. the formulas in Appendix 3.A).
The model-free estimate of the cross ratio can be based on an alter-
native, asymptotic representation. Given (Ti1, Ti2) and (Tk1, Tk2), two
randomly selected clusters (among
(s
2
)
possible pairs), let
γ(r) =
Pr
(
(Ti1 − Tk1)(Ti2 − Tk2) > 0
∣∣∣Rik = r)
Pr
(
(Ti1 − Tk1)(Ti2 − Tk2) < 0
∣∣∣Rik = r)
with
Rik = #
{
` ∈ {1, . . . , s}: T`1 ≥ min(Ti1, Tk1), T`2 ≥ min(Ti2, Tk2)
}
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If r/s→ v as s→∞ and r →∞, then it can be shown that γ(r)→ ζ?(v)
(Oakes, 1989). Accordingly, a non-parametric estimate of γ(r) can be
used as a substitute for a non-parametric estimate of ζ?(v). The non-
parametric estimate of γ(r) proposed in Oakes (1989) follows by counting
the number of concordances and discordances among the pairs of clusters
such that Rik = r. More details can be found in Duchateau & Janssen
(2008, Section 4.2.6). Some technical improvements of the method are
proposed in Viswanathan & Manatunga (2001) and in Chen & Bandeen-
Roche (2005).
Note: limitations of the method
There are problems inherent to the use of γ(r) as a substitute for
ζ?(v):
• To determine the concordance/discordance status of a pair,
observations within a cluster must have an ordering.
• In the presence of censoring, there are cases where the con-
cordance/discordance status cannot be ascertained. In Oakes
(1989), this problem is circumvented by assuming complete
data (no censoring).
This calls for a new non-parametric estimator of the cross ratio
that does not require the use of γ(·), or that can at least deal with
censoring (see, e.g., Lakhal et al. (2009)).
3.2.3 Association patterns (early/late)
Another time-dependent association measure, with a simple probability
interpretation, is given by (Anderson et al., 1992)
ψ(t1, t2) =
S(t1, t2)
S1(t1)S2(t2)
= Pr(T1 > t1 |T2 > t2)Pr(T1 > t1)
with S(·, ·) the joint survival function of (T1, T2), and S1(·) and S2(·) the
marginal survival functions of T1 and T2. Large values of ψ(·, ·) indicate
positive association while unity indicates no association.
In Figure 3.1, contour plots of ψ(·, ·) depict the evolution of the de-
pendence graphically for the gamma and the positive stable frailty dis-
tributions (Duchateau & Janssen, 2008, Chapter 4). The gamma frailty
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distribution is characterised by late dependence (contour lines are very
close together at late times) while the positive stable frailty distribution
is characterised by early dependence (contour lines indicating positive
dependence appear early). As the next section will formalise, this can
be explained by the behaviour of the frailty distribution in the tails.
On the one hand, the positive stable frailty distribution has a heavy
right tail (cf. Figure 3.2), leading to strong dependence initially. On the
other hand, the gamma frailty distribution has a lot of probability mass
skewed to the left (cf. Figure 3.2), leading to strong dependence at late
times.
We conclude that the tails of the frailty distribution play an impor-
tant role in the way the dependence changes over time.
3.3
Quantile dependence
To capture the behaviour in the tails, we introduce an additional local
measure of dependence, namely quantile dependence.
3.3.1 Definitions
Quantile dependence is a measure of local association between two ran-
dom variables, here (T1, T2). The lower quantile dependence coefficient
λ`(q) is defined for q ∈ (0, 1) as
λ`(q) = Pr
(
T1 ≤ F−11 (q)
∣∣T2 ≤ F−12 (q))
with F−11 (·) and F−12 (·) the quantile functions of T1 and T2. Thus, λ`(q)
is the conditional probability that member 1 fails before time F−11 (q),
given that member 2 failed before time F−12 (q). Under independence,
λ`(·) is the identity function. If we let q approach zero, then we obtain
the lower tail dependence coefficient,
Λ` = lim
q→0λ`(q)
The upper counterparts, λu(·) and Λu, are similarly defined,
λu(q) = Pr
(
T1 > F
−1
1 (q)
∣∣T2 > F−12 (q))
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Figure 3.1: Contour plots of ψ(t1, t2) for the gamma frailty distribu-
tion (upper panel) and for the positive stable frailty distribution (lower
panel), with frailty parameter chosen so that τ = 0.4.
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Figure 3.2: Density of W = log(U), for U following the gamma (Gam),
the inverse Gaussian (IG), and the positive stable (PS) frailty distri-
butions, with frailty parameter chosen so that τ = 0.4. From the log
densities, it can be seen that the gamma distribution has a large left
tail, that the positive stable has a large right tail, and that the inverse
Gaussian takes a position in between.
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and
Λu = lim
q→1λu(q)
A distribution is said to display lower tail dependence if Λ` > 0 and
upper tail dependence if Λu > 0. Tail independence means that extreme
events occur independently in both tails (Λ` = 0 and Λu = 0).
In terms of the joint survival function, λ`(q) and λu(q) are written
as
λ`(q) =
S
(
F−11 (q), F−12 (q)
)
+ 2q − 1
q
(3.1)
and
λu(q) =
S
(
F−11 (q), F−12 (q)
)
1− q (3.2)
In the frailty model framework, the joint survival function has the
following Laplace transform representation (Oakes, 1989)
S(t1, t2) = L
{
L−1
(
S1(t1)
)
+ L−1
(
S2(t2)
)}
By plugging this representation of S(t1, t2) into (3.1) and (3.2), we obtain
λ`(q) =
L
{
2L−1(1− q)
}
+ 2q − 1
q
(3.3)
and
λu(q) =
L
{
2L−1(1− q)
}
1− q (3.4)
3.3.2 Association patterns
In Figure 3.3, plots of λ`(q) and λu(q) versus q depict the evolution of
the dependence graphically for the gamma, the inverse Gaussian, and
the positive stable frailty distributions. The explicit forms, obtained by
substituting the corresponding Laplace transforms into (3.3) and (3.4),
are given in Appendix 3.A. The gamma frailty distribution displays
upper tail dependence (Λ` = 0 and Λu > 0), the positive stable frailty
distribution displays lower tail dependence (Λ` > 0 and Λu = 0), and
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the inverse Gaussian frailty distribution yields independence in both
tails (Λ` = 0 and Λu = 0).
As
λu(q) =
qλ`(q)− 2q + 1
1− q
we now focus solely on λ`(q).
3.3.3 Model-based estimate
To obtain a model-based estimate λˆ`(q) of λ`(q), we plug an estimate of
the frailty parameter into the Laplace transform in (3.3). An estimate of
the frailty parameter can be obtained by fitting the frailty model. In this
chapter, we use the R library parfm as it is, to date, the only package that
supports all the above-mentioned frailty distributions (cf. Chapter 2).
The standard error of λˆ`(q) can be derived from the standard error of
the frailty parameter by using the delta method. Simulation results for
the bias and standard error of λˆ`(q) are shown in Appendix 3.C.
3.3.4 Model-free estimate
To obtain a model-free estimate λ˜`(q) of λ`(q), we plug a non-parametric
estimate of the joint survival function in (3.1). There is, at present,
no fully satisfactory general solution to this non-parametric estimation
problem (Hougaard, 2000, Chapter 14). However, non-parametric es-
timation of the joint survival function becomes quite straightforward
under mild, common, and often reasonable assumptions regarding the
censoring mechanism (Wang & Wells, 1997).
Given a bivariate cluster of event times (T1, T2), possibly right-
censored by (C1, C2), the random variables that we observe are Y1 =
min(T1, C1), ∆1 = I(T1 ≤ C1), Y2 = min(T2, C2), and ∆2 = I(T2 ≤ C2).
We allow for the presence of a binary covariate that indicates position in
a cluster (e.g., treatment arm). Finally, we denote by S(·, ·) and G(·, ·)
the joint survival functions of (T1, T2) and (C1, C2), respectively.
Under the common hypothesis of independence between the event
times and the censoring times, we have
S(t1, t2) =
Pr(Y1 > t1, Y2 > t2)
G(t1, t2)
(3.5)
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Figure 3.3: Lower and upper quantile dependence coefficients for the
gamma (Gam), the inverse Gaussian (IG), and the positive stable (PS)
frailty distributions, with frailty parameter chosen so that τ = 0.4.
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The numerator, i.e. the joint survival function of the observables (Y1, Y2),
can be estimated by the empirical survival function. Estimation of the
denominator, i.e. the joint survival function of the censoring times, is
similar to the estimation of S(t1, t2), but can be simplified if the relation-
ship between C1 and C2 is of simple form, as often the case in practice.
Common scenarios include:
• independent censoring (C1 ⊥⊥ C2):
G(t1, t2) = Pr(C1 > t1) Pr(C2 > t2)
• univariate censoring (C1 = C2 = C):
G(t1, t2) = Pr
(
C > max(t1, t2)
)
In these cases, estimation of G(·, ·) reduces to a univariate estimation
problem (Kaplan-Meier method).
In (3.5), we need to take tj = Fˆ−1j (q), with Fˆ−1j (·) the Kaplan-Meier
quantile function of Tj (j = 1, 2). In the absence of covariates, paired
observations are exchangeable and we can use an overall Kaplan-Meier
quantile function.
The standard error of λ˜`(q) can be obtained by means of the non-
parametric bootstrap for clustered survival data (Therneau & Gramb-
sch, 2000, page 249; Ren et al., 2010).
Simulation results for the bias and standard error of λ˜`(q) are shown
in Appendix 3.C.
3.3.5 Quantile dependence as a diagnostic tool
We propose to use the quantile dependence function as a diagnostic tool
for the frailty distribution in the shared frailty model. By comparing
a model-based estimate with the model-free estimate over a grid of q-
values, we obtain a graphical assessment of the frailty distribution.
The model-free estimator from Section 3.3.4 requires bivariate data,
i.e. clusters of size 2. However, clustered survival data often involve
larger and varying cluster sizes. As an ad-hoc solution, we propose to
obtain λ˜`(q) as
λ˜`(q) =
1
B
B∑
b=1
λ˜
(b)
` (q)
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for some B  0, with λ˜(b)` (q) the non-parametric estimate of λ`(q) based
on a bivariate data set obtained by selecting two observations at random
in each cluster (respecting the ordering, if any).
3.4
Examples
Example 1
The standard technique to assess when a fracture has healed in dogs is
based on radiography. To evaluate the use of ultrasonography as an al-
ternative technique, each of 106 dogs was evaluated for time to fracture
healing with the two techniques (Duchateau & Janssen, 2008, Exam-
ple 1.2). Since each dog serves as its own control, there is likely to be
dependence in the data. Each cluster is of size 2 and can be ordered
according to the binary covariate (radiography versus ultrasound). Fur-
ther, there is no censoring. Under these conditions, the diagnostic plot
based on the cross ratio discussed in Section 3.2.2 can be used. We also
use the proposed graphical tool based on quantile dependence. The two
diagnostic plots are shown in Figure 3.4. The model-based estimates are
obtained by using a log-logistic baseline hazard function in the frailty
model. It appears from both diagnostic plots that the dependence struc-
ture is well captured by the positive stable frailty distribution.
Example 2
As a second illustrative example, we consider data on 100 dairy cows
which were followed up for infection (mastitis) in one or more udder
quarters (Duchateau & Janssen, 2008, Example 1.4). Observations are
at the udder quarter level. Each cluster is thus of size 4. About 20% of
the observations are censored (no infection occurred during follow-up),
with censoring at the cow level. The diagnostic plot based on the cross
ratio function discussed in Section 3.2.2 does not apply to this partic-
ular example as (i) observations in a cluster are exchangeable (clusters
cannot be ordered), and (ii) some of the observations are censored. The
proposed diagnostic plot based on quantile dependence is shown in Fig-
ure 3.5. The model-based estimates are obtained by using a Weibull
baseline hazard function in the frailty model. It appears that the positive
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Figure 3.4: Diagnostic plots for Example 1. The dots represent the
model-free estimates at discrete points.
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stable frailty distribution is suitable to model the dependence structure
in these data.
The gamma distribution has been rejected for these data by a formal
goodness-of-fit test in Geerdens et al. (2013). To confirm this conclu-
sion using the proposed diagnostic plot, the data can be resampled under
the hypothesis that the frailty term is gamma distributed; cf. the thesis
appendix (Appendix 3). The upper panel of Figure 3.6 shows 500 boot-
strap model-based estimates of λ`(·) obtained from the gamma frailty
model together with the model-free estimate. The model-free estimate
deviates substantially from the bootstrap estimates. The gamma frailty
distribution assumption is thus called into question (thus confirming the
result in Geerdens et al. (2013)). In the lower panel of Figure 3.6, the
data are resampled under the hypothesis that the frailty term follows a
positive stable distribution and the bootstrap model-based estimates of
λ`(·) are obtained from the positive stable frailty model. It is clear from
the lower panel of Figure 3.6 that the positive stable distribution is a
better choice than the gamma to model the frailty term.
3.5
Simulations
In this section, we use simulations to study the performance of the pro-
posed diagnostic tool with respect to the number of clusters/observations
per cluster ((s, n) = (150, 4), (75, 8), (50, 12), (30, 20), and (20, 30)) and
amount of censoring (20% and 40%).
Event times are generated from the frailty model with a Weibull
baseline hazard (h0(t) = λρtρ−1, with λ = 0.7 and ρ = 1.5) and a binary
covariate dividing each cluster into two balanced groups (β = −0.4);
cf. the thesis appendix (Appendix 2). The frailty term follows either
a gamma (Gam), an inverse Gaussian (IG), or a positive stable (PS)
distribution. The frailty parameter is chosen so that Kendall’s τ equals
0.4.
We run 1000 simulations. For each simulation, we compute the L2-
distance between the model-free estimate of λ`(·) and the three model-
based estimates (Gam, IG, and PS). Table 3.1 reports the selection
percentage for each frailty distribution, i.e. the proportion of times that
each frailty distribution is selected by the diagnostic plot (based on the
smallest distance value). Specific comments are as follows:
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Figure 3.5: Diagnostic plot for Example 2. In this plot, the discrete
model-free estimate has been smoothed by means of locally-weighted
polynomial regression (cf. the lowess() function in R).
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Figure 3.6: Diagnostic plot for Example 2 supplemented with 500 boot-
strap model-based estimates obtained under the gamma (upper panel)
or the positive stable (lower panel) frailty distribution assumption.
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• The standard assumption for the frailty term is that it follows a
gamma distribution. Therefore, the most common form of mis-
specification is that of using the gamma distribution while the
actual frailty distribution is not gamma. This type of misspecifi-
cation is detected by the proposed diagnostic plot.
• Distinction between the incorrect inverse Gaussian and the correct
frailty distribution may be difficult in some settings. Indeed, there
is a tendency for the inverse Gaussian model-based estimate of
λ`(·) to get close to the correct model-based estimate. It is note-
worthy that an inverse Gaussian frailty term cannot model high
levels of dependence (Kendall’s τ < 12 ; cf. Appendix 3.A).
• Increasing the number of clusters appears to be more beneficial
than increasing the number of observations per cluster. However,
moderately large cluster sizes are needed when censoring limits the
amount of information within a cluster.
3.6
Discussion
Diagnostic plots have proven to be useful in survival analysis, e.g. to
check the assumption of proportional hazards in the Cox model. Diag-
nostic plots are generally not intended to replace formal tests, but are
certainly useful companions to guide the model selection.
In the shared frailty model, different frailty distributions induce dif-
ferent dependence structures in the data. Based on this observation, we
have constructed a diagnostic plot for the frailty distribution by compar-
ing an empirical to a model-based estimate of the quantile dependence
coefficient. The main motivation for using quantile dependence as a
diagnostic tool was to capture the behaviour of the frailty distribution
in the tails, a key feature that drives the way dependence changes over
time.
Model-based estimates of the quantile dependence coefficient can be
obtained by fitting the frailty model with different frailty distributions
(cf. Section 3.3.3). The empirical estimate is developed for bivariate
data (cluster of size 2), with possibly a binary covariate indicating po-
sition in a cluster (cf. Section 3.3.4). If additional covariate information
is available, the empirical estimate can be obtained based on a binary
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Table 3.1: Simulation results – selection percentages for each frailty
distribution.
censoring true: Gam true: IG true: PS
Gam IG PS Gam IG PS Gam IG PS
(s, n) = (150, 4)
20% 85 15 0 1 86 13 0 19 81
40% 72 28 0 12 71 17 1 23 76
(s, n) = (75, 8)
20% 94 6 0 7 87 6 2 30 68
40% 73 27 0 11 80 9 4 26 70
(s, n) = (50, 12)
20% 71 29 0 1 69 30 0 28 72
40% 47 53 0 2 72 26 0 22 78
(s, n) = (30, 20)
20% 57 43 0 0 59 41 0 33 67
40% 26 74 0 0 59 41 0 18 82
(s, n) = (20, 30)
20% 41 58 1 0 53 47 0 31 69
40% 14 85 1 0 56 44 0 21 79
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prognostic index combining the information on several risk factors into
a single value indicative of the prognosis of the subject (“low-risk group”
versus “high-risk group”). Larger and varying cluster sizes can be han-
dled by using pairwise comparisons (cf. Section 3.3.5).
The proposed diagnostic plot is suitable for any frailty distribution
for which the Laplace transform and its inverse can be evaluated (cf.
Equation 3.3).
Overall, the proposed diagnostic plot provides a simple, readily avail-
able, and broadly applicable tool that can be used on its own or that
can serve as a supplement to the few existing goodness-of-fit tests.
More discussion is provided at the end the thesis (closing part).
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Appendix 3.A
Explicit formulas
Gamma frailty distribution (θ > 0):
f(u) = (
1/θ)1/θ u(1/θ)−1 exp (−(1/θ)u)
Γ(1/θ)
L(x) =
(
1 + θx
)− 1/θ
L−1(x) = 1
θ
(
x−θ − 1
)
τ = θ
θ + 2
β = 4
(
2θ+1 − 1
)− 1/θ − 1
ζ?(v) = θ + 1
λ`(q) =
(
2(1− q)−θ − 1
)− 1/θ
+ 2q − 1
q
λu(q) =
(
2(1− q)−θ − 1
)− 1/θ
1− q
Λ` = 0
Λu = 2
− 1/θ
Inverse Gaussian frailty distribution (θ > 0):
f(u) = 1√
2piθ
u−3/2 exp
(
− 12θu (u− 1)
2
)
L(x) = exp
{1
θ
(
1−√1 + 2θx
)}
L−1(x) = log(x)2
(
θ log(x)− 2
)
τ = 12 −
1
θ
+ 2
θ2
exp
(2
θ
)∫ ∞
2/θ
u−1 exp(−u) du < 12
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β = 4 exp
{
1
θ
(
1−
√
2
(
θ log(2) + 1
)2 − 1)}− 1 < 2(2−√2) − 1
ζ?(v) = 1 + 1(1/θ)− log(v)
λ`(q) =
L
{
log(1− q)
(
θ log(1− q)− 2
)}
+ 2q − 1
q
λu(q) =
L
{
log(1− q)
(
θ log(1− q)− 2
)}
1− q
Λ` = 0
Λu = 0
Positive stable frailty distribution (0 < θ < 1):
f(u) = − 1
piu
∞∑
k=1

Γ
(
k(1− θ) + 1
)
k! sin
(
(1− θ)kpi
) (
−uθ−1
)k
L(x) = exp
(
− x1−θ
)
L−1(x) =
(
− log(x)
)1/(1− θ)
τ = θ
β = 4 exp
{
−21−θ log(2)
}
− 1
ζ?(v) = 1− θ(1− θ) log(v)
λ`(q) =
exp
{
21−θ log(1− q)
}
+ 2q − 1
q
λu(q) =
exp
{
21−θ log(1− q)
}
1− q
Λ` = 2
(
1− 2−θ
)
Λu = 0
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Appendix 3.B
Kendall’s τ versus θ
In the frailty model framework, Kendall’s τ can be computed as (cf.
Section 3.2.1)
τ = 4
∫ ∞
0
xL(x)L(2)(x) dx− 1
which involves the frailty parameter θ through L(x). Kendall’s τ can
therefore be used to interpret the value of θ.
In Table 3.2, we give the values of θ that correspond to a sequence of
values of τ for the gamma, the inverse Gaussian, the positive stable, and
the log-normal frailty distributions. For the inverse Gaussian and the
log-normal, these values are obtained by means of a numerical method
rather than an explicit formula.
Inverse Gaussian frailties
The integral that appears in the formula of Kendall’s τ of an IG frailty
term (cf. Appendix 3.A) is an incomplete gamma function. This inte-
gral is also known as the exponential integral (Abramowitz & Stegun,
1972, Chapter 5). The exponential integral, and therefore Kendall’s
τ , has no solution in terms of elementary functions. Column 3 of Ta-
ble 3.2 has therefore been obtained by means of numerical integration
(cf. gamma_inc() in R, part of the gsl library).
Table 3.2: Kendall’s τ versus θ.
τ
0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90
Gam 0.22 0.50 0.86 1.33 2.00 3.00 4.67 8.00 18.0
θ
IG† 0.28 0.81 2.03 6.20
PS 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90
LN 0.23 0.56 1.06 1.95 3.59 6.69 13.0 27.9 74.7
† The Kendall’s τ of an IG frailty term is always lower than 1/2.
Chapter 3 60
Log-normal frailties
There is no explicit evaluation of the Laplace transform for log-normal
frailties. Consequently, there is no explicit formula for Kendall’s τ . In
Section 2.4.6, we show how to approximate, for a given x ≥ 0, the
Laplace transform of a log-normal frailty term and its derivatives. This
makes it possible to evaluate Kendall’s τ using adaptive quadrature (cf.
integrate() in R).
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Appendix 3.C
Model-free and model-based estimators of λ`(q)
Table 3.3: Simulation results – Estimates of λ`(q) and their empirical
and estimated standard errors (SEs) in 1000 simulated data sets (cf.
Section 3.5) based on the model-free (cf. Section 3.3.4) and model-based
(cf. Section 3.3.3) estimators. Each simulated data set consists of 100
clusters of size 2 and has approximately 20% of censored observations.
q
true mean emp. mean
value est. SE SE
frailty dist: Gam – estimator: model-free
0.10 0.206 0.256 0.153 0.147
0.25 0.438 0.440 0.106 0.095
0.50 0.702 0.704 0.063 0.057
0.75 0.877 0.875 0.044 0.042
0.90 0.956 0.941 0.039 0.034
frailty dist: Gam – estimator: model-based Gam
0.10 0.206 0.207 0.021 0.021
0.25 0.438 0.438 0.032 0.032
0.50 0.702 0.701 0.029 0.028
0.75 0.877 0.877 0.016 0.016
0.90 0.956 0.956 0.007 0.007
frailty dist: IG – estimator: model-based IG
0.10 0.356 0.356 0.074 0.073
0.25 0.543 0.537 0.051 0.051
0.50 0.710 0.705 0.022 0.022
0.75 0.843 0.842 0.007 0.007
0.90 0.929 0.929 0.002 0.002
frailty dist: PS – estimator: model-based PS
0.10 0.524 0.524 0.056 0.055
0.25 0.586 0.586 0.046 0.046
0.50 0.699 0.700 0.030 0.030
0.75 0.830 0.830 0.014 0.014
0.90 0.923 0.923 0.005 0.005

Part II
Heterogeneity in multicentre trials

4Adjusting for centre heterogeneity in
multicentre clinical trials with a
time-to-event outcome
Clinical trials are conducted at multiple centres for two main reasons:
to accrue the required number of patients in a relatively short period of
time and to broaden the scope of the results. Considerable efforts are
made to standardise the way the trial is conducted in each centre ac-
cording to the study protocol. The fact remains, however, that patients
from different centres usually have different prognosis due to differences
between centres (differences in disease diagnosis, differences in referral
patterns, differences in indications for background therapies, etc.). In
statistical terms, variability in outcome between patients within an in-
dividual centre tends to be lower than variability in outcome between
patients at different centres (centre heterogeneity). For more reading on
that and related issues, see Localio et al. (2001).
The International Conference on Harmonisation (ICH) guidance doc-
ument E9 “Statistical Principles for Clinical Trials” (Lewis, 1999) clearly
states that “The main treatment effect may be investigated first using a
model which allows for centre differences, but does not include a term for
the treatment-to-centre interaction.” For multicentre clinical trials with
a time-to-event endpoint, however, recommendations on how to adjust
for centre heterogeneity are limited. Inclusion of fixed effects and strat-
ification are common methods to adjust for risk factors. Frailty models
are not yet widely used in practice. Robustness properties against frailty
misspecification have to be studied to build confidence in the frailty
model.
In the setting of multicentre clinical trials, the fixed effects, stratified,
and frailty approaches to estimating the treatment effect are reviewed
and contrasted in Glidden & Vittinghoff (2004). Based on that paper,
and along the lines of Chu et al. (2011), Kahan & Morris (2013), and
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Kahan (2014) where the cases of continuous and binary outcomes are
discussed, this chapter aims at providing guidelines for the practising
statistician in the pharmaceutical industry. Using simulations, the per-
formance of the frailty modelling approach over competing methods is
illustrated. Special attention is paid to the problem of frailty misspeci-
fication. The central question addressed in this chapter is whether the
frailty approach is the method to be recommended, considering the fact
that frailty misspecification is the rule, rather than the exception.
In Section 4.1, we review the basics of the fixed effects, stratified, and
frailty approaches. Section 4.2 highlights the limitations of ignoring cen-
tre heterogeneity as well as the pros and the cons of the aforementioned
modelling strategies to adjust for centre heterogeneity. To illustrate this
discussion, we use numerical results from a simulation study. We fur-
ther investigate the performance of the frailty model when the frailty
distribution is misspecified in Section 4.3. Section 4.4 summarises the
conclusions and presents our recommendations.
The material presented in this chapter is published in Munda &
Legrand (2014a).
4.1
Modelling clustered time-to-event data
We start with non-clustered time-to-event data for which the observed
information consists of
Z =
{
(yj , δj ,xj) | j = 1, . . . , N
}
where yj = min(tj , cj) is the time to event or censoring, whichever comes
first, δj = I(tj ≤ cj) indicates whether an observation corresponds to an
event (δj = 1) or is censored (δj = 0), and xj is a vector of covariates.
We make the standard assumption of independent and non-informative
censoring (cf. Section 1.2.2).
Let hj(t) denote the hazard rate of subject j at time t. The (unad-
justed) Cox model is written as
hj(t) = h0(t) exp(x′jβ) (4.1)
with h0(·) a non-specified baseline hazard function and β = (β1 . . . βp)′
a vector of fixed effects parameters. See Section 1.2.6 for more details.
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Model (4.1) requires independent (homogeneous) data up to mea-
sured covariates. In multicentre clinical trial data, however, there is
likely to be heterogeneity across centres. To account for centre hetero-
geneity, centre effects must somehow be included in the statistical model
used for the analysis. Below, the fixed effects, stratified, and frailty ap-
proaches to estimating the treatment effect in the presence of centre
heterogeneity are described in a nutshell. For more details, see Glidden
& Vittinghoff (2004).
The fixed effects Cox model
Centre effects can enter model (4.1) as additional fixed effects parame-
ters,
hij(t) = h0(t) exp(c′iα+ x′ijβ) (4.2)
where we now use two indices, i ∈ {1, . . . , s} for the s centres and
j ∈ {1, . . . , ni} for the ni patients in centre i, to reflect the hierarchical
structure of the data (the vector of observations Z is changed accord-
ingly). In model (4.2), α = (α1 . . . αs−1)′ contains the fixed centre
effects, and ci denotes the vector with a 1 in the ith position and 0’s
elsewhere (i = 1, . . . , s − 1). The last centre does not need an indi-
cator because an observation is known to belong to that centre when
ci = (0 . . . 0)′. If we had included an additional indicator for the last
centre, then the model would have been overparametrised. Choosing
one particular centre as reference is consistent with the interpretation of
h0(·) as being the hazard rate of subjects with covariate values all equal
to 0. However, this choice is arbitrary, and any centre can play the role
of the reference centre.
The stratified Cox model
Instead of entering the centre variable as additional fixed effects param-
eters, the baseline hazard can be stratified on that variable to indicate
that different subpopulations are exposed to different baseline risks, i.e.
hij(t) = h0i(t) exp(x′ijβ) (4.3)
where h01(·), . . . , h0s(·) are unspecified and unrelated baseline hazard
functions. The partial likelihood approach (cf. Section 1.2.6) is readily
adapted by multiplying the partial likelihoods specific to each stratum.
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The use of model (4.3) to adjust for centre heterogeneity is recommended
in O’Quigley & Stare (2002).
The frailty model
Participating centres may also be viewed as one possible sample from
a broader population of centres. In that case, centre i has a random
effect, called frailty and denoted by ui, on the hazard rate. The frailty
term reflects different levels of risk across centres. The (shared) frailty
model is defined as
hij(t) = h0(t)ui exp(x′ijβ) (4.4)
The ui’s are the actual values of a random variable U with probability
density f(·), called the frailty distribution. The (one-parameter) gamma
distribution (cf. Section 1.1 of the thesis appendix) is the most commonly
used. In that case, E(U) = 1 and Var(U) = θ. The frailty parameter
determines the degree of heterogeneity between centres.
Software
We use coxph() in R (part of the survival library) to fit models (4.1)–
(4.4). For a detailed description of the proper use of coxph() for frailty
models, see Therneau & Grambsch (2000, Chapter 9). Generic sample
codes are provided in Appendix 4.A.
4.2
Comparison
In this section, we discuss the strengths and the weaknesses of mod-
els (4.2)–(4.4) to adjust for centre heterogeneity. This discussion is il-
lustrated with simulations. Because the unadjusted model (4.1) is often
used in practice, we consider this model as well.
4.2.1 Simulation setting
We consider two opposite situations with 6 centres of size 48 (N = 6×48)
and 48 centres of size 6 (N = 6×48) as well as an intermediate situation
with 8 centres of size 18 plus 24 centres of size 6 (N = 8× 18 + 24× 6),
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thus keeping the total sample size fixed at N = 288. We mimic a
1:1 (respectively 2:1) allocation ratio in each centre by selecting N/2
(respectively 2N/3) patients for the treatment arm (x = 1) and the
remaining N/2 (respectively N/3) patients for the control arm (x = 0).
The event time for each patient is generated from model (4.4) using
a Weibull baseline hazard (h0(t) = λρtρ−1) and a gamma frailty term
with variance θ; cf. the thesis appendix (Appendix 2). We take λ = 0.7,
ρ = 1.5, θ = 0.5 (Kendall’s τ = 0.20), and β = log(2/3) ≈ −0.405 or
β = 0. The between-centre heterogeneity induced by this parameter
setting is shown in Figure 4.1 by the spread in the median time to
event from centre to centre (Duchateau & Janssen, 2005). The censoring
time for each patient is generated from an exponential distribution with
rate parameter chosen so that 30% of the observations are censored.
Additional simulation results (varying the censoring rate and Kendall’s
τ) are available at http://onlinelibrary.wiley.com/doi/10.1002/
pst.1612/suppinfo.
For each setting, we fit models (4.1)–(4.4) to K = 10000 simulated
data sets. For model (4.4), we use the correctly specified gamma frailty
distribution (the impact of misspecification is addressed separately in
Section 4.3). We report
• HR: the average estimate of the hazard ratio, i.e. 1K
∑
k exp(βˆk);
• SD: the standard deviation of the βˆk’s;
• CI cov: the empirical coverage of the asymptotic 95% confidence
interval based on the normal approximation, i.e. the proportion of
such confidence intervals that cover the true value of β;
• power/size: the empirical rejection rate for the null hypothesis of
no treatment effect (H0: β = 0)—under H0, it equals 1 minus the
empirical coverage probability.
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Note: power
Note that by disregarding the clustering under this parameter set-
ting, one will expect to have approximately a 80% chance of declar-
ing a hazard ratio of HR = 2/3 to be significant at the 5% level.
Indeed, power calculation for the Cox model can be done by means
of the following formula (see, e.g., Collett, 2003, Section 10.2.1)
power ≈ Φ
(
zα/2 − log(HR)
√
d pi(1− pi)
)
with
• Φ(·): the standard normal cumulative distribution function;
• zα/2: the α/2 quantile of the standard normal distribution;
• d: the expected number of events, i.e. total sample size× (1−
censoring rate);
• pi: the proportion of individuals allocated to the control group.
Therefore, the power to detect a hazard ratio of HR = 2/3 at the 5%
significance level with a sample size of 288 subjects and a censoring
rate of 30% is of 0.82 under a 1:1 allocation ratio, and of 0.77 under
a 2:1 allocation ratio.
Note: assessment of coverage
Let pic be the true coverage probability and X the number of times
the confidence interval covers β out of K replications; then X ∼
Bin(K,pic). The empirical estimator pc = X/K has an asymp-
totic normal distribution with mean pic and variance pic(1 − pic)/
K so that the width of its 95% confidence interval is approximately
2
√
pic(1− pic)/K, which is bounded from above by
√
1/K. With
K = 10000, the width of that confidence interval is therefore at
most equal to 0.01. Hence, empirical coverage probabilities below
0.945 correspond to under-coverage and empirical coverage proba-
bilities above 0.955 correspond to over-coverage (Burton et al., 2006;
Demirtas, 2007).
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Figure 4.1: Density function of the median time to event from centre to
centre (control group) in the setting of the simulation study.
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4.2.2 Results and guidelines
The results are displayed in Table 4.1 (β = log(2/3) ≈ −0.405) and in
Table 4.2 (β = 0).
The unadjusted Cox model
Model (4.1) makes no attempt to account for clustering. This alters the
way the treatment effect (HR = exp(β)) has to be interpreted. Indeed,
HR has different meanings in model (4.1) (marginal model) and in mod-
els (4.2)–(4.4) (conditional models). In model (4.1), HR compares the
hazard rates of two subjects, one treated and one untreated, randomly
drawn from the population under study, regardless of where they come
from (population-averaged interpretation). On the other hand, in con-
ditional models (and in particular in model (4.4) used to generate the
data), HR compares the hazard rates of two subjects, one treated and
one untreated, randomly drawn from the same centre (centre-specific
interpretation). Therefore, in our simulations, the unadjusted model
estimates a quantity that is different from the target. In Table 4.1,
we observe that the population-averaged effect is attenuated compared
with the centre-specific effect. Under the null hypothesis of no treatment
effect (Table 4.2), HR is well estimated (as there is no room for atten-
uation), but it can be seen from the type I error rate that ignoring the
clustering leads to results that are too conservative. For more general
results regarding the omission of important risk factors from non-linear
regression models, see Hauck et al. (1998).
The fixed effects Cox model
Model (4.2) requires maximisation over a (p + s − 1)-parameter space,
with p the number of parameters in β (here, p = 1). This is numerically
challenging whenever the number of centres, s, is large relative to the
total sample size. The fixed effects approach therefore performs poorly
for s = 8+24 and for s = 48. It produces estimates that are biased away
from the true β, and the coverage of the confidence interval (respectively
the type I error rate) is below 95% (respectively above 5%). Regarding
multicentre clinical trials, the fixed effects approach further shows addi-
tional limitations. (i) It implicitly assumes that the centres participating
in the trial are by themselves of interest. Inference is to be made for
those centres only, and conclusions are thus restricted in scope. (ii) It
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Table 4.1: Simulation results for the treatment effect, with β = log(2/
3) ≈ −0.405, under correct specification of the frailty distribution.
model†
sample size statistic (4.1) (4.2) (4.3) (4.4)
1:1
6 × 48 HR 0.731 0.668 0.673 0.674
SD 0.133 0.148 0.149 0.145
CI cov 0.929 0.948 0.954 0.953
power 0.617 0.809 0.784 0.798
8 × 18 HR 0.742 0.645 0.674 0.674
+24× 6 SD 0.127 0.173 0.168 0.153
CI cov 0.918 0.910 0.944 0.944
power 0.582 0.814 0.701 0.772
48× 6 HR 0.743 0.627 0.675 0.675
SD 0.123 0.184 0.173 0.150
CI cov 0.925 0.890 0.954 0.955
power 0.572 0.825 0.656 0.764
2:1
6 × 48 HR 0.730 0.668 0.673 0.674
SD 0.141 0.158 0.159 0.154
CI cov 0.939 0.945 0.948 0.950
power 0.580 0.768 0.736 0.755
8 × 18 HR 0.740 0.644 0.674 0.674
+24× 6 SD 0.134 0.177 0.172 0.158
CI cov 0.935 0.917 0.954 0.952
power 0.545 0.780 0.665 0.732
48× 6 HR 0.742 0.628 0.675 0.675
SD 0.132 0.195 0.182 0.160
CI cov 0.933 0.893 0.951 0.950
power 0.535 0.781 0.620 0.719
† model (4.1): unadjusted Cox model; model (4.2): fixed effects
Cox model; model (4.3): stratified Cox model; model (4.4): semi-
parametric gamma frailty model.
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Table 4.2: Simulation results for the treatment effect, with β = log(1) =
0, under correct specification of the frailty distribution.
model†
sample size statistic (4.1) (4.2) (4.3) (4.4)
1:1
6 × 48 HR 1.007 1.009 1.010 1.009
SD 0.128 0.149 0.151 0.146
size 0.031 0.055 0.052 0.052
8 × 18 HR 1.010 1.016 1.015 1.013
+24× 6 SD 0.124 0.170 0.164 0.150
size 0.024 0.074 0.050 0.047
48× 6 HR 1.011 1.020 1.017 1.014
SD 0.123 0.187 0.173 0.152
size 0.022 0.090 0.049 0.051
2:1
6 × 48 HR 1.008 1.011 1.012 1.011
SD 0.134 0.157 0.158 0.154
size 0.028 0.053 0.049 0.048
8 × 18 HR 1.007 1.014 1.013 1.010
+24× 6 SD 0.129 0.178 0.171 0.157
size 0.022 0.074 0.050 0.048
48× 6 HR 1.006 1.017 1.016 1.011
SD 0.130 0.198 0.183 0.162
size 0.024 0.094 0.050 0.053
† model (4.1): unadjusted Cox model; model (4.2): fixed effects
Cox model; model (4.3): stratified Cox model; model (4.4): semi-
parametric gamma frailty model.
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provides neither a summary measure of heterogeneity between centres
nor a convenient framework to test for the presence of centre effects
(Andersen et al., 1999). (iii) It might be of interest to assess whether
a covariate explains heterogeneity in outcome between centres (Legrand
et al., 2006). It is, however, unfeasible in this model to include a covari-
ate whose values only change at the centre level. (iv) Precision in centre
effects estimates is dependent upon the centre size. Interpretation can
therefore be misleading. A related problem is that the centre effects es-
timates (and their interpretation) depend on the choice of the reference
centre, which is generally arbitrary.
The stratified Cox model
Model (4.3) performs well, with good point estimates and good cover-
age probabilities. However, no between-centre comparisons are made by
the stratified approach (information about β only comes from within-
centre comparisons). In particular, centres where subjects have the same
covariate values and centres with no event do not contribute any infor-
mation. Therefore, the stratified approach does not make optimal use of
all the information at hand. This explains why both the standard devi-
ation inflates and the power deteriorates when the centre size decreases.
Besides, similar to the fixed effects approach, (i) interpretation of the
treatment effect is restricted to participating centres, (ii) no heterogene-
ity measure is returned, and (iii) centre-specific covariates cannot be
investigated because no between-centre comparisons are made by the
stratified approach.
The frailty model
Model (4.4) shows good performances in every investigated setting with
virtually no bias and good coverage probabilities. Unlike the stratified
model, the frailty model also makes use of between-centre comparisons
to gather information on the treatment effect. This explains why both
the standard deviation is smaller and the power is better for the frailty
model than for the stratified model. Compared to the fixed effects ap-
proach, the number of parameters in the frailty model does not increase
with the number of centres. The frailty modelling approach further
provides a rich framework for the analysis of multicentre clinical trials.
(i) Because of their random nature, the actual values of the frailty term
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(i.e. the centre effects for those centres participating in the trial) are not
of intrinsic interest, and the conclusions of the study are intended to be
generalised more broadly to all hospitals represented by the sample at
hand. (ii) The variance of the gamma frailty distribution, θ, is a key
parameter that determines the degree of heterogeneity between centres.
To help interpretation, this parameter can further be translated into
clinically relevant quantities like the spread in the median time to event
(as we did in Figure 4.1) or in the 5-year survival rate from centre to
centre (Duchateau & Janssen, 2005). Alternatively, the θ parameter can
be transformed into the Kendall’s τ that measures the degree of associ-
ation between outcomes within the same centre (cf. Section 3.2.1). For
gamma frailties, Kendall’s τ is τ = θ/(θ + 2). (iii) Considering the ui’s
as random effects parameters also makes it possible to study whether
the inclusion of a centre-specific covariate explains/reduces heterogene-
ity between centres (Legrand et al., 2006).
4.3
Robustness against frailty misspecification
Different distributions can be used to model the frailty term. Diagnos-
tic checks to assess the frailty distribution are not yet widely available
(particularly in software), and research is still needed in this area (cf.
Chapter 3). In the meantime, it is important to investigate robustness
properties against frailty misspecification via simulations.
The most common assumption is that the frailties have a gamma
distribution. Therefore, the most common form of misspecification is
that of using the gamma distribution while the frailties actually follow
another distribution. Alternative distributions that have received in-
terest to model the frailty term include the inverse Gaussian (IG), the
log-normal (LN), and the positive stable (PS).
To observe the impact of misspecifying the frailty distribution on the
inference for the treatment effect (and more generally for the fixed effects
parameters included in the model), we simulate data from model (4.4)
(cf. Section 4.2.1) using the IG, LN, and PS distributions to generate
the frailties, and we fit the misspecified gamma frailty model. For each
frailty distribution, the heterogeneity parameter is chosen to yield a
Kendall’s τ of τ = 0.20, as earlier.
By comparing the results obtained under misspecification with those
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obtained under correct specification (Table 4.3 and Table 4.4), it ap-
pears that inferences on the fixed effect parameter β are robust against
misspecification of the frailty distribution. In particular, the frailty ap-
proach performs better than the competing stratified approach in terms
of power in either misspecified situation.
4.4
Conclusions
In clinical trials with a time-to-event outcome, the primary analysis is
commonly based on model (4.1) with a single covariate for the treatment
effect, or on the equivalent log-rank test. When the trial is conducted
at multiple centres, the treatment effect obtained from model (4.1) has
a population-averaged (marginal) interpretation, the effect being aver-
aged over all centres. Model (4.1) leads to a consistent estimate of the
population treatment effect, but the standard error is not consistent
and a robust estimator that copes with the clustering should be used
(cf. the cluster() argument in coxph()); see Glidden & Vittinghoff
(2004) and Duchateau & Janssen (2008, Section 3.4). In contrast, the
treatment effect obtained from models (4.2)–(4.4) has a centre-specific
(conditional) interpretation. In the context of multicentre clinical trials,
the centre-specific treatment effect interpretation is particularly relevant
as it compares “like-for-like”.
Important conclusions from our simulation study are as follows:
• The population-averaged effect is attenuated compared with the
centre-specific effect;
• Ignoring the clustering leads to results that are too conservative;
• The centre-specific treatment effect is usually biased when it is
estimated from the fixed effects Cox model (4.2);
• In some settings, power is lost when fitting the stratified Cox
model (4.3) compared with the frailty model (4.4);
• Inferences on the centre-specific treatment effect obtained from the
frailty model (4.4) are robust against misspecification of the frailty
distribution in many settings.
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In the light of these results, we recommend to use the frailty model,
which is now readily available in standard software (e.g. R and SAS),
to adjust for centre heterogeneity in multicentre clinical trials with a
time-to-event outcome.
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Appendix 4.A
Sample codes
Models (4.1)–(4.4) can be fitted in R by means of coxph() (part of the
survival library) or in SAS by means of proc phreg. In the generic
sample codes below, data has the following columns:
• cluster: cluster identification number;
• time: minimum between the actual event time and the censoring
time;
• status: 1 if the observation is an event, 0 if it is right-censored;
• x: treatment group indicator (0 or 1).
R codes
# unadjusted Cox model
coxph(Surv(time, status) ~ x, data=data)
# fixed effects Cox model
coxph(Surv(time, status) ~ x + factor(cluster), data=data)
# stratified Cox model
coxph(Surv(time, status) ~ x + strata(cluster), data=data)
# semi−parametric gamma frailty model
# !!! ‘sparse=(nclass > 5)’ !!!
# cf. Therneau & Grambsch, 2000, Section 9.7
coxph(Surv(time, status) ~ x +
frailty.gamma(x=cluster, eps=1e−11),
outer.max=50, data=data)
SAS codes
/* unadjusted Cox model */
proc phreg data=data;
class x(ref="0");
model time*status(0) = x / ties=efron;
run;
/* fixed effects Cox model */
proc phreg data=data;
class x(ref="0") cluster(ref="1");
model time*status(0) = x cluster / ties=efron;
run;
/* stratified Cox model */
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proc phreg data=data;
class x(ref="0");
model time*status(0) = x / ties=efron;
strata cluster;
run;
/* semi−parametric log−normal frailty model */
/* !!! The gamma frailty distribution is not yet available !!! */
/* A likelihood reformulation method for non−normal random effects,
with sample codes in proc nlmixed, is described in Liu & Yu
(2008) */
proc phreg data=data;
class x(ref="0") cluster;
model time*status(0) = x / ties=efron;
random cluster / method=REML;
run;
5Testing for decreasing heterogeneity
between hospitals in time to death
from chronic myeloid leukemia
In the standard frailty model, the frailty term is assumed to be con-
stant over time. For some particular studies, this assumption is known
to be questionable. For example, the cancer clinical trial on chronic
myeloid leukemia (CML) analysed in Wintrebert et al. (2004) is one
such study. Patients first receive bone marrow transplantation, whence
they are at risk of death due to transplant-related causes. Within that
period, substantial heterogeneity between transplant centres can be fore-
seen. Thereafter, heterogeneity is expected to decrease.
In this chapter, we relax the time-constant heterogeneity assumption
and consider frailty models with a time-varying frailty term. Instead of
working with hazard models, we rather model the log cumulative hazard
function, making use of the mixed model framework, and introduce a
time-varying random effect at that level.
Section 5.1 presents a literature review and lays out the framework of
this chapter. In Section 5.2, we introduce the time-varying frailty model
and we show how to estimate the fixed effects, how to predict the time-
varying random effect, and how to test for time-varying heterogeneity
using the linear mixed model methodology. The proposed method is
illustrated in Section 5.3 with the CML data mentioned above. In Sec-
tion 5.4, we run simulations to assess the performance of the method.
Concluding remarks are given in Section 5.5.
This chapter is submitted for publication (Munda et al., 2014).
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5.1
Literature review and outline
Much of the work on time-varying frailties has concerned recurrent event
time data. In Yau & McGilchrist (1998), the log frailty term is allowed
to vary according to a first-order autoregressive (AR(1)) process to de-
scribe serial dependence between recurrent event times. A generalisation
of the frailty model estimation of McGilchrist (1993), which is based
on (restricted) maximum likelihood, is presented. The model is illus-
trated with recurrent infection data on chronic granulomatous disease
patients. A related approach for the proportional odds model is devel-
oped in Lam et al. (2002). The model of Yau & McGilchrist (1998) is
applied within the Bayesian framework in Manda & Meyer (2005). In
Wang et al. (2007), the model is augmented with an additional (time-
constant) shared frailty term to accommodate situations involving both
clusters and recurrent events. This multilevel model is illustrated with
data on recurrent urinary tract infections among elderly women resid-
ing in aged-care institutions. In Yue & Chan (1997), the frailty term
is assumed to have a two-parameter gamma distribution, with parame-
ters updated at each recurrence according to the past information. In
essence, the updated scheme in Yue & Chan (1997) modifies the AR(1)
process for the case of gamma random variables. This specification leads
to a closed-form expression for the marginal likelihood. This model is
further studied in Fong et al. (2001). The Bayesian model in Pennell
& Dunson (2006) allows the frailty term to vary between time inter-
vals, using Dirichlet priors to allow for uncertainty in the gamma frailty
distribution.
For univariate survival data (no cluster), time-varying frailty models
based on Lévy processes are studied in Gjessing et al. (2003).
In the context of multicentre clinical trials, differences between cen-
tres, e.g. in terms of practice patterns or patient management, may have
an important influence on study outcomes at the beginning of follow-
up, but less so afterwards, especially when patients have recovered suf-
ficiently to leave the hospital. To model time-varying centre effects on
survival after bone marrow transplantation in CML patients, a shared
frailty model with a piecewise constant frailty term (Paik et al., 1994) is
proposed in Wintrebert et al. (2004). To be specific, the frailty of clus-
ter i in interval k is taken to be the sum of independent two-parameter
gamma random variables, Uik = Ui + Eik. The cluster-specific frailty
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component Ui models heterogeneity between clusters. Within cluster i,
the independent interval-specific frailty components (the Eik’s) allow the
overall frailty term to vary over time. To simplify the model estimation,
which is based on maximum likelihood, two alternatives are proposed.
The first one sets Uik = Uγki , with Ui log-normal and γk an unknown
interval-specific parameter. The second one assumes that the log frailty
term is a linear function of time with random centre-specific intercepts
and slopes, log(Ui(t)) = ai+bit where (ai, bi)′ follows a bivariate normal
distribution. Application to the CML data indicates that heterogeneity
between transplant centres decreases over time.
In this chapter, we propose an alternative model to study time-
varying centre heterogeneity in large-scale multicentre clinical trials.
Following Massonnet et al. (2008), Teodorescu et al. (2010), and López-
de-Ullibarri et al. (2012), survival models can be based on the logarithm
of the cumulative hazard. The key idea is that, on the logarithmic scale,
the cumulative hazard function has a linear model structure. Random
effects can then be introduced at that level, leading to a linear mixed
effects model. Provided that enough data information is available, com-
plex data structures can be studied in that framework. Furthermore,
linear mixed effects models can be handled by standard software, e.g.
proc mixed in SAS.
To model decreasing (or, more generally, time-varying) heterogeneity
between clusters on a time-to-event endpoint, we therefore propose to
model the logarithm of the estimated cumulative hazard as a linear
mixed effects model with a time-varying random effect.
5.2
Time-varying frailty model
The focus on this chapter is on heterogeneity in large-scale multicentre
clinical trial data. We consider the following data structure. Observa-
tions are partitioned into s clusters and each cluster is divided into two
groups by a dichotomous covariate x (e.g., a treatment indicator or a
prognostic biomarker whose value is used to partition the population
into two risk groups). Let hij(t) denote the hazard rate at time t for
individual j of cluster i (j = 1, . . . , ni; i = 1, . . . , s). The frailty model
is defined as
hij(t) = h0(t)ui exp(xijβ)
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= h0(t) exp(wi + xijβ) (5.1)
where h0(·) is a baseline hazard function, xij is the value of the covariate
(0 or 1), β is the unknown fixed effect parameter, and wi = log(ui) is
the log frailty, hereafter called random effect, of cluster i. An alternative
formulation of model (5.1) in terms of the cumulative hazard function is
Hij(t) = H0(t) exp(wi + xijβ)
Since we use the linear mixed model methodology, a convenient choice
for the distribution of the wi’s is the normal distribution with mean 0
and variance θ.
The extension that we propose is of form
Hij(t) = H0(t) exp(wi(t) + xijβ) (5.2a)
That is, the wi’s are time-dependent at the cumulative hazard level.
Note: model constraint
In order for Hij(·) in model (5.2a) to be a cumulative hazard func-
tion, we need to ensure that
1. limt→0Hij(t) = 0
2. limt→∞Hij(t) =∞
3. dHij(t)dt ≥ 0 for all t
The first two conditions are satisfied. Condition 3 can be rewritten
as
dH0(t)
dt +H0(t)
dwi(t)
dt ≥ 0
On the one hand, if wi(·) is constant or increasing, this condition is
satisfied. On the other hand, if wi(·) is decreasing, then condition 3
is that log(H0(·)) increases faster than wi(·) decreases.
The hazard function derived from model (5.2a) is
hij(t) =
(
h0(t) +H0(t)
dwi(t)
dt
)
exp(wi(t) + xijβ)
Therefore, the way we extend the frailty model is different from exten-
sions where the wi’s are time-dependent in (5.1) (cf., e.g., Wintrebert
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et al. (2004)). It is interesting to note that exp(β) still has a conditional
hazard ratio interpretation.
Using a logarithmic transformation on both sides of (5.2a), we have
log
(
Hij(t)
)
= log
(
H0(t)
)
+ wi(t) + xijβ (5.2b)
Model (5.2b) provides the bridge between the survival model (5.2a) and
the linear mixed effects model (see Section 5.2.1).
Note: hazard model versus cumulative hazard model
An alternative extension is
hij(t) = h0(t) exp(wi(t) + xijβ) (5.3a)
i.e., the wi’s are time-dependent at the hazard level. On the loga-
rithmic scale, (5.3a) also has a linear model structure,
log
(
hij(t)
)
= log
(
h0(t)
)
+ wi(t) + xijβ (5.3b)
To arrive at linear mixed effects models, we need “pseudo-responses”
which will serve as responses in (5.2b) and (5.3b). In this chapter,
the pseudo-responses are obtained non-parametrically. In order to
make this as simple as possible, we work with (5.2b) rather than
with (5.3b).
5.2.1 Towards the linear mixed effects model
Let Tij be the event time of individual j from cluster i, possibly right-
censored by the random variable Cij (j = 1, . . . , ni; i = 1, . . . , s). We
make the standard assumptions that the event times and the censoring
times are independent conditional on the frailty term and the covari-
ate (independent censoring) and that the censoring distribution has no
common parameter with the event time distribution (non-informative
censoring). For each i and j, the random variables that we observe are
Yij = min(Tij , Cij) and ∆ij = I(Tij ≤ Cij), together with the covari-
ate xij ∈ {0, 1}. We denote by H(k)i (·) the cumulative hazard function
common to all individuals of cluster i with xij = k (k = 0, 1).
To arrive at a linear mixed effects model, we need “pseudo-responses”
which will serve as responses in model (5.2b). In group k of cluster i, the
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pseudo-responses φˆik,` are obtained by estimating φik,` := log
(
H
(k)
i (t`)
)
on a fixed grid of time points t`; ` = 1, . . . , L. The grid of time points can
often be based on clinical or biological grounds. Practical considerations
regarding the choice of the t`’s are further discussed for the CML data
in Section 5.3.
Using the data from cluster i, {(yij , δij , xij) | j = 1, . . . , ni}, we take
φˆik,` = log
(
Hˆ
(0)
i (t`) exp(kγˆi)
)
with Hˆ(0)i (·) an estimator of H(0)i (·) and γˆi the fixed effect parameter
estimate obtained from the Cox model fitted to the data of cluster i. For
Hˆ
(0)
i (·), we propose a modification of the Breslow cumulative baseline
hazard curve by combining this non-parametric estimator with a para-
metric fit to estimate H(0)i (t`) for t` below the first or above the last
event time of cluster i.
Note: a hybrid estimator of H0(·)
Given a sample of independent survival data (up to a vector of
measured covariates x), the Breslow estimator of the cumulative
hazard function is defined by
Hˆ0B(t) =
∑
y˜(`)≤t
d`∑
j∈R(y˜(`)) exp(x
′
jβˆ)
with y˜(1) < · · · < y˜(r) the ordered distinct event times, d` the number
of events at time y˜(`), and R(y˜(`)) the set containing those individ-
uals still under observation just prior to y˜(`). This estimator suffers
from two limitations: (i) it returns zero below y˜(1) (regarding the
logarithmic transformation, this is a problem), and (ii) it remains
constant beyond y˜(r) (estimates are thus not reliable in the right
tail). We therefore propose to complete Hˆ0B(·) using a parametric
distribution to estimate the tails (Moeschberger & Klein, 1985)
Hˆ0(t) =

λˆtρˆ if t < y˜(1)
Hˆ0B(t) if y˜(1) ≤ t ≤ y˜(r)
Hˆ0B(y˜(r)) + λˆ
(
tρˆ − y˜ρˆ(r)
)
if t > y˜(r)
with λˆ and ρˆ obtained by fitting a Weibull distribution to the data
where x = 0 under the constraint that λˆy˜ρˆ(1) = Hˆ0B(y˜(1)).
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In terms of the pseudo-responses, we have
φˆik,` = β0,` + wi,` + kβ + eik,` (5.4)
with β0,` := log
(
H0(t`)
)
, wi,` := wi(t`), and eik,` := φˆik,` − φik,`.
Model (5.4) is a linear mixed effects model with the following as-
sumptions:
• w = (w1,1 . . . w1,L . . . . . . ws,1 . . . ws,L)′ ∼ N(0,G)
• e = (e10,1 e11,1 . . . e10,L e11,L . . . . . . es0,1 es1,1 . . . es0,L es1,L)′
∼ N(0,R)
• Cov(w, e) = 0
where the forms of the G and R matrices are specified in Section 5.2.2
and in Section 5.2.3, respectively. For more details on the model struc-
ture, we refer the reader to Appendix 5.A where we give the matrix
formulation for model (5.4).
5.2.2 Random effects covariance structure
Random effects pertaining to different clusters are assumed to be inde-
pendent so that
Cov(wi,`, wi′,`′) = 0 if i 6= i′
Consequently, theGmatrix has a block diagonal structure, with s blocks
of size L × L. We further assume that the blocks are identical. The
common block matrix specifies the covariance structure between the L
random effects within the same cluster. Many different choices can be
made (Littell et al., 2000). When the t`’s are equally spaced, a popular
choice is the AR(1) structure, i.e.
Cov(wi,`, wi,`′) = θ ρ|`−`
′| (θ > 0, 0 < ρ < 1)
In words, the between-cluster variability is the same at any point while
association between pairs of random effects within the same cluster de-
clines with increasing distance in time. However, the fact that the vari-
ance remains constant over time makes it impossible to assess whether
the cluster-to-cluster variability is changing over time. For that purpose,
an autoregressive structure with heterogeneous variances (ARH(1)) is
more appropriate, i.e.
Cov(wi,`, wi,`′) =
√
θ`
√
θ`′ ρ
|`−`′|
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5.2.3 Residual covariance structure
In model (5.4), the error term eik,` adjusts for the fact that we have
substituted an estimate for φik,`. The R = Var(e) = Var(φˆ |w) matrix
specifies the covariance structure of the error terms. By construction,
this information cannot be recovered from the pseudo-data (the latter do
not contain any replicate for given i, k, and `). In addition to the pseudo-
responses, therefore, the raw data also have to provide an estimate of
R. This can be done by bootstrap resampling.
The fact that φˆi0,` and φˆi1,` (` = 1, . . . , L) are constructed using
only the data from cluster i results in a block diagonal structure for
R, with s blocks of size 2L × 2L. In addition, block i differs from
block i′ because clusters are generally not identical in terms of sample
size and event rate. We obtain an estimate of Cov(eik,`, eik′,`′) as follows.
First, we draw B bootstrap samples from cluster i of the original data
(Davison & Hinkley, 1997, Algorithm 7.2, page 351). For each bootstrap
sample, we calculate the pseudo-responses φˆ?ik,` and φˆ?ik′,`′ . An estimate
of Cov(eik,`, eik′,`′) then follows from the empirical covariance between
the φˆ?ik,`’s and the φˆ?ik′,`′ ’s.
5.2.4 Fitting the model
Model (5.4) can be fitted in SAS by means of proc mixed where the
parms statement is used to fix the residual variance components.
sample code
proc mixed data=pseudoData method=reml scoring=8;
class cluster timepoint x;
model phi = timepoint x;
random timepoint / subject=cluster type=arh(1);
repeated / subject=cluster group=cluster type=un;
parms / parmsdata=covPar hold=%eval(&length_covParG + 1) to
&length_covPar;
run;
*’length_covPar’ is the total number of variance components;
*’length_covParG’ is the number of variance components in G;
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5.2.5 Testing for decreasing heterogeneity
To see whether “a time-constant cluster-to-cluster variability” is a rea-
sonable model assumption, we can test the null hypothesis
H0: θ1 = · · · = θL
against the alternative
H1: ∃`, `′ ∈ {1, . . . , L} : θ` 6= θ`′
Under H0, each block of G has a homogeneous AR(1) structure. The
AR(1) structure has 2 parameters (θ and ρ) as compared to L+1 param-
eters (θ1, . . . , θL, and ρ) for the ARH(1) structure. Model comparison
can be done via a (restricted) likelihood ratio test (Littell et al., 2006,
Section A1.6).
For the CML study considered in Section 5.3, however, we are mostly
interested in decreasing heterogeneity among clusters. In that case, we
rather consider the ordered alternative
H1: θ1 > · · · > θL
To account for the ordering specified under H1, we rely on the ordered
heterogeneity family of tests (Rice & Gaines, 1994a,b). An ordered het-
erogeneity test can be used to convert almost any non-directional test
into a directional one when a specific ordered test is not available or is
though to implement. The test statistic consists of combining a measure
of evidence against H0 with the independent ordering information spec-
ified under H1. In our case, the test statistic becomes TO = rs(1−plrt),
with plrt the p-value obtained from the (non-directional) likelihood ra-
tio test, and rs the Spearman’s rank correlation between the observed
ranking of {θˆ1, . . . , θˆL} and the expected ranking under the alternative.
The test statistic TO becomes increasingly large as the data increasingly
refute the null hypothesis in the direction of the alternative hypothesis
(Rice & Gaines, 1994a). Critical values are tabulated in Rice & Gaines
(1994b).
5.3
Example
We consider the CML data used in Wintrebert et al. (2004). To obtain
good pseudo-responses, sufficient data information is required within
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each cluster. In the CML data, many centres are quite small (number
of patients per centre: min = 1, 1st quartile = 3, median = 10, mean =
19.43, 3rd quartile = 23.5, max = 280) and substantial data information
is censored (≈ 60%). We thus consider a subset of the data, leaving a
sample of 1767 CML patients from 19 centres among which 706 deaths
(≈ 40%) were recorded (cf. Table 5.1).
We account for the effects of five known risk factors (patient age,
disease stage, time interval from diagnosis to transplant, donor type,
and donor-recipient sex combination). To avoid the “curse of dimen-
sionality”, we incorporate the covariate information into the EBMT risk
score (Gratwohl, 2012), a validated prognostic index ranging from 0 to 7
points, from which we identify a “low-risk group” (EBMT risk score =
0, 1, 2, 3) and a “high-risk group” (EBMT risk score = 4, 5, 6, 7). By
fitting the standard frailty model (5.1) with the normal random effect
distribution we find a hazard ratio of ĤR = exp(βˆ) = 2.140 (95% CI:
[1.827, 2.507]) and θˆ = 0.025.
To investigate whether the centre-to-centre variability decreases over
follow-up time, we fit model (5.4). Pseudo-responses are calculated on
a grid of L = 5 time points equally spaced between t1 = 1 month and
t5 = 9 months, which is approximately the time it takes for a patient to
recover and to produce normal blood cell levels.
Regarding the fixed effect obtained from model (5.4), we find ĤR =
exp(βˆ) = 2.116 (95% CI: [1.693, 2.643]), similar to what we have ob-
tained with the standard frailty model.
Figure 5.1 displays the empirical best linear unbiased predictions
(EBLUPs) of the random effects under the ARH(1) specification of the
G matrix (cf. Section 5.2.2). The value of the variance at the different
time points (i.e. the diagonal elements of each block of G) are given at
the bottom of Figure 5.1.
The likelihood ratio statistic (AR(1) versus ARH(1)) equals 17.655.
As convergence to the limiting null chi-squared distribution is slow (this
point is further discussed in the simulations below), we rather make
use of the finite-sample distribution obtained by bootstrapping the data
under H0 (cf. Appendix 3). We find plrt = 0.038. The correlation
coefficient between the observed ranking (5, 4, 3, 2, 1) and the expected
ranking (5, 4, 3, 2, 1) equals rs = 1. Thus, TO = 0.962. For L = 5,
the critical region C at the 5% significance level is C = {TO > 0.509}.
We therefore reject H0 and we conclude that the data display declining
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Table 5.1: Repartition of the patients in the CML data. In parentheses
are the number of events.
centre low-risk high-risk total
x = 0 x = 1
1 31 (8) 19 (7) 50 (15)
2 41 (13) 11 (3) 52 (16)
3 52 (12) 6 (6) 58 (18)
4 48 (15) 11 (4) 59 (19)
5 53 (9) 7 (12) 60 (21)
6 49 (17) 12 (6) 61 (23)
7 52 (13) 10 (11) 62 (24)
8 53 (16) 14 (8) 67 (24)
9 52 (16) 16 (9) 68 (25)
10 41 (23) 27 (3) 68 (26)
11 55 (20) 15 (8) 70 (28)
12 60 (20) 12 (8) 72 (28)
13 51 (21) 21 (9) 72 (30)
14 66 (16) 7 (16) 73 (32)
15 67 (27) 14 (9) 81 (36)
16 85 (29) 21 (10) 106 (39)
17 121 (42) 64 (41) 185 (83)
18 145 (61) 78 (32) 223 (93)
19 206 (82) 74 (44) 280 (126)
total 1328 (460) 439 (246) 1767 (706)
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Figure 5.1: Empirical best linear unbiased predictions (EBLUP’s) as a
function of time in the CML study. The evolution of the variance over
time is shown below the x-axis.
centre heterogeneity. Figure 5.1 indicates that there is heterogeneity
between centres during the first few months following transplantation,
but not much afterwards.
Different time points, varying in number and position, are considered
in Figure 5.2 and Figure 5.3. It appears that the choice of the particular
time points is not critical, provided that sufficient data information is
available for each cluster during the considered time window. On the
one hand, t1 should not be taken too small to ensure enough variability
in the pseudo-responses at t1. On the other hand, tL should not be taken
too large to avoid results driven by the particular distribution used to
model the upper tail. A suitable choice of t1 and tL can be determined by
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inspecting the Kaplan-Meier curve stratified by cluster (cf. Figure 5.4).
5.4
Simulation study
To provide further insight into the method, we have conducted a simu-
lation study in the context of a large-scale multicentre clinical trial.
We consider 10 centres of size 200 or 400. Patients within a centre
are randomly assigned to one of two treatment groups with an allocation
ratio of 1:1. Three scenarios are examined:
• Scenario 1: event times are generated from model (5.1), i.e. the
wi’s are time-constant;
• Scenario 2: event times are generated from model (5.2a), i.e. the
wi’s are time-dependent at the cumulative hazard level;
• Scenario 3: event times are generated from model (5.3a), i.e. the
wi’s are time-dependent at the hazard level.
In all three scenarios, we take β = log(2) ≈ 0.693 and we use a Weibull
distribution at baseline (h0(t) = λρtρ−1) with λ = 0.005 and ρ = 2.
Censoring times are generated from an exponential distribution with
rate parameter chosen to control the amount of censoring. We consider
moderate censoring (20%) and high censoring (60%).
5.4.1 Generation of event times
To generate tij , the event time for patient j of centre i, we use the fact
that Sij(Tij) ∼ U(0, 1) and we solve Sij(tij) = u for tij , with u a uniform
variate. The forms of Sij(t) in the three scenarios are
• Scenario 1: Sij(t) = exp
{
− λtρ exp(wi + xijβ)
}
• Scenario 2: Sij(t) = exp
{
− λtρ exp(wi(t) + xijβ)
}
• Scenario 3: Sij(t) = exp
{
−
∫ t
0
λρvρ−1 exp(wi(v) + xijβ) dv
}
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Figure 5.2: Same as Figure 5.1 with L = 4.
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Figure 5.3: Same as Figure 5.1 with L = 6.
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Figure 5.4: Kaplan-Meier curve (restricted to the first 3 years) stratified
by transplant centre showing that most deaths occur during the first 9
months.
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In scenario 1, wi is randomly drawn from a N(0, θ) distribution,
with θ = 0.56 or θ = 1.06. To help interpretation, the θ parameter
can be transformed into the Kendall’s τ that measures the degree of
association between event times in a centre. For θ = 0.56 and θ =
1.06, this transformation gives τ ≈ 0.20 and τ ≈ 0.30, respectively (cf.
Appendix 3.B).
In scenarios 2 and 3, the specific time-dependency in the random
effects that we consider is depicted in Figure 5.5. The time-dependency
dies out in time (wi(t)→ 0 as t→∞). The actual value of the random
effect in cluster i at time t = 0, wi(0), is sampled from a N(0, θ) distribu-
tion. We take θ = 0.56 and θ = 1.06, as above. Given the random start,
the way the time-dependency dies out is deterministic. For details, we
refer the reader to Appendix 5.B where we explain how Figure 5.5 is
obtained.
5.4.2 Results
For each of 500 simulations, we have fitted model (5.4) with both the
AR(1) and ARH(1) specifications of the G matrix. For the ARH(1)
specification, we have recorded the EBLUP’s of the random effects and
the estimated variances over time. Figures 5.6–5.8 display averages at
each time point for one particular parameter setting in the three scenar-
ios (results are similar for the other parameter settings). The estimates
of the fixed effect parameter β were also obtained (cf. Table 5.3).
The density of the likelihood ratio statistic is depicted in Figure 5.9
for increasing sample sizes. The likelihood ratio statistic converges to the
limiting chi-squared distribution with (L + 1) − 2 degrees of freedom.
Convergence is slow, though. Therefore, in practice, we recommend
using the finite-sample distribution obtained by bootstrapping the data
under the null hypothesis (cf. Appendix 3).
In the context of these simulations, to avoid prohibitively long simu-
lation times, we have determined the null distribution of the test statistic
TO by simulations, using supplementary simulated data sets, rather than
by bootstrap. The rejection rates for the ordered heterogeneity test are
given in Table 5.2. Important conclusions are as follows:
• The rejection rate under the alternative hypothesis of scenarios 2
and 3, i.e. the power of the test, is generally reasonably high;
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Figure 5.5: Declining heterogeneity between clusters as used in the sim-
ulation study. In this picture, the initial values correspond to the deciles
of the N(0, θ) distribution, with θ = 1.06. In the simulations, the initial
values are randomly drawn from the N(0, θ) distribution, with θ = 0.56
or θ = 1.06.
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Figure 5.6: Simulation results in scenario 1 with cluster size = 400,
censoring rate = 60%, and θ = 1.06.
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Figure 5.7: Simulation results in scenario 2 with cluster size = 400,
censoring rate = 60%, and θ = 1.06.
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Figure 5.8: Simulation results in scenario 3 with cluster size = 400,
censoring rate = 60%, and θ = 1.06.
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• The power decreases with decreasing data information (i.e. de-
creasing cluster size and/or increasing censoring);
• For θ (initial variance) decreasing, also the power is decreasing;
• The power remains reasonably high even under model misspecifi-
cation (cf. scenario 3).
5.5
Discussion
We have proposed a method to test for decreasing heterogeneity in clus-
tered survival data by extending the frailty model to a time-varying
frailty model. Starting from the cumulative hazard representation, the
method embeds the model into the linear mixed model world via a log-
arithmic transformation. Pseudo-responses for the linear mixed model
are derived by estimating the log cumulative hazard on a grid of time
points.
Within each cluster, sufficient data information is needed for ac-
curate estimation of the pseudo-responses. Therefore, the method is
intended for applications that involve big clusters, e.g. large-scale mul-
ticentre clinical trials. For the same reason, we recommend the use
of a prognostic index to handle multiple covariates. For a continuous
prognostic index, the Breslow estimator used to compute the pseudo-
responses can be replaced by a kernel-based estimator (see López-de-
Ullibarri et al., 2012).
We have illustrated the method with the same CML data as in Win-
trebert et al. (2004) and confirmed the conclusion that heterogeneity
between transplant centres declines over time. Of note, the way we ex-
tend the frailty model is different from extensions given in Wintrebert
et al. (2004) where the random effects are made time-dependent in the
hazard function. Compared to the latter, the proposed method is flex-
ible in specifying the correlation structure between the random effects,
avoids complex likelihood functions that are difficult to maximize, and
offers the ability to use standard mixed model software.
More discussion is provided at the end the thesis (closing part).
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Table 5.2: Simulation results – Ordered heterogeneity test.
θ cens. size rejectionrate
scenario 1
0.56 20% 200 0.045
400 0.060
60% 200 0.065
400 0.070
1.06 20% 200 0.032
400 0.065
60% 200 0.045
400 0.035
scenario 2
0.56 20% 200 0.630
400 0.813
60% 200 0.623
400 0.783
1.06 20% 200 0.791
400 0.946
60% 200 0.776
400 0.907
scenario 3
0.56 20% 200 0.591
400 0.780
60% 200 0.570
400 0.765
1.06 20% 200 0.754
400 0.953
60% 200 0.838
400 0.942
Chapter 5 106
Table 5.3: Simulation results – Fixed effect parameter.
θ cens. size βˆ se(βˆ) 95% CI(β)median median coverage
scenario 1
0.56 20% 200 0.686 0.053 0.954
400 0.688 0.037 0.966
60% 200 0.686 0.075 0.948
400 0.688 0.052 0.950
1.06 20% 200 0.688 0.053 0.940
400 0.691 0.037 0.946
60% 200 0.680 0.075 0.964
400 0.686 0.052 0.952
scenario 2
0.56 20% 200 0.697 0.053 0.952
400 0.693 0.037 0.940
60% 200 0.682 0.075 0.944
400 0.684 0.052 0.948
1.06 20% 200 0.686 0.053 0.974
400 0.692 0.037 0.952
60% 200 0.684 0.074 0.944
400 0.689 0.052 0.948
scenario 3
0.56 20% 200 0.694 0.053 0.944
400 0.692 0.037 0.928
60% 200 0.687 0.075 0.944
400 0.687 0.052 0.942
1.06 20% 200 0.686 0.053 0.956
400 0.693 0.037 0.956
60% 200 0.676 0.074 0.966
400 0.688 0.052 0.954
The true β equals log(2) ≈ 0.693.
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Figure 5.9: Finite-sample distribution of the likelihood ratio statistic
under H0 (censoring rate = 60%; θ = 0.56).
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Appendix 5.A
Model (5.4) in matrix notation
In matrix form, the linear mixed effects model is written as
Y = Xβ +Zw + e
w∼ N(0,G)
e ∼ N(0,R)
Cov(w, e) = 0
with Y the vector of responses, β and w the vectors of fixed and random
effects parameters, X and Z the corresponding design matrices, and e
the vector of random errors.
Below is the matrix form of model (5.4) for the particular case where
s = 3 and L = 2:

φˆ10,1
φˆ11,1
φˆ10,2
φˆ11,2
φˆ20,1
φˆ21,1
φˆ20,2
φˆ21,2
φˆ30,1
φˆ31,1
φˆ30,2
φˆ31,2

=

1 0 0
1 0 1
0 1 0
0 1 1
1 0 0
1 0 1
0 1 0
0 1 1
1 0 0
1 0 1
0 1 0
0 1 1


β0,1
β0,2
β
 +

1 0 0 0 0 0
1 0 0 0 0 0
0 1 0 0 0 0
0 1 0 0 0 0
0 0 1 0 0 0
0 0 1 0 0 0
0 0 0 1 0 0
0 0 0 1 0 0
0 0 0 0 1 0
0 0 0 0 1 0
0 0 0 0 0 1
0 0 0 0 0 1


w1,1
w1,2
w2,1
w2,2
w3,1
w3,2

+

e10,1
e11,1
e10,2
e11,2
e20,1
e21,1
e20,2
e21,2
e30,1
e31,1
e30,2
e31,2

Y = X β + Z w + e
In general, we have
X =
(
1s ⊗ IL ⊗ 12 1s ⊗ 1L ⊗
(0
1
) )
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and
Z = Is ⊗ IL ⊗ 12
with In the n×n identity matrix and 1n the vector of length n with all
entries equal to 1.
Continuing the particular case where s = 3 and L = 2, G = Var(w)
and R = Var(e) = Var(Y |w) are block diagonal matrices,
G = diag(G1,G2,G3) and R = diag(R1,R2,R3)
with Gi and Ri the symmetric matrices
Gi =
(
Var(wi,1) Cov(wi,1, wi,2)
Var(wi,2)
)
and
Ri =

Var(ei0,1) Cov(ei0,1, ei1,1) Cov(ei0,1, ei0,2) Cov(ei0,1, ei1,2)
Var(ei1,1) Cov(ei1,1, ei0,2) Cov(ei1,1, ei1,2)
Var(ei0,2) Cov(ei0,2, ei1,2)
Var(ei1,2)

The covariance matrix of Y = φˆ, given by ZGZ ′ +R, is thus a block
diagonal matrix with block i is given by
Var

φˆi0,1
φˆi1,1
φˆi0,2
φˆi1,2

=

θ1 θ1
√
θ1
√
θ2ρ
√
θ1
√
θ2ρ
θ1 θ1
√
θ1
√
θ2ρ
√
θ1
√
θ2ρ√
θ1
√
θ2ρ
√
θ1
√
θ2ρ θ2 θ2√
θ1
√
θ2ρ
√
θ1
√
θ2ρ θ2 θ2
+Ri
Appendix 5.B
Generation of time-varying random effects
For data generation purposes, we assume that the differential equation
dwi(t)
dt = k1i exp
{
−
(
t− k2
k3
)2}
wi(0) = wi0
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describes the evolution in time of wi(t), where k1i is a parameter that
governs the increasing/decreasing rate, and where k2, k3 are two addi-
tional tuning constants related to “where variation takes place and how
long it lasts”. The solution of the differential equation is given by
wi(t) = w0i + k1ik3
√
pi
[
Φ
(√
2 t− k2
k3
)
+ Φ
(√
2 k2
k3
)
− 1
]
where Φ(·) denotes the cumulative distribution function of a standard
normal random variable. Taking
k1i = − w0i
k3
√
piΦ
(√
2 k2k3
)
we obtain that the cluster-to-cluster variability dies out in time (wi(t)→
0 as t→∞).
We now need to ensure that, for this choice of wi(t),
Hij(t) = H0(t) exp(wi(t) + xijβ)
does result in a cumulative hazard curve, i.e.,
1. limt→0Hij(t) = 0
2. limt→∞Hij(t) =∞
3. dHij(t)dt ≥ 0 for all t
The first two conditions are satisfied. Assuming a Weibull baseline haz-
ard (h0(t) = λρtρ−1; λ > 0, ρ > 0), condition 3 can be rewritten as
λtρ exp(wi(t) + xijβ)
(
ρ
t
+ dwi(t)dt
)
≥ 0
from which it follows that we must have
ρ
t
≥ −dwi(t)dt
for all t > 0 and i ∈ {1, . . . , s}. If wi(t) is constant or increasing, then
the constraint always holds. Otherwise, this condition is most easily
interpreted from model (5.2b),
log
(
Hij(t)
)
= log
(
H0(t)
)
+ wi(t) + xijβ
In that case, the constraint means that the rate at which log
(
H0(t)
)
(whose derivative is ρt ) increases must be larger than the rate at which
wi(t) decreases in order for log
(
Hij(t)
)
, or equivalently for Hij(t), to be
increasing.

Part III
Spatial dependence

6A first step towards modelling spatial
dependence in time to malaria data
using the frailty model methodology
Malaria is found in tropical and subtropical regions where meteorological
and environmental conditions (temperature, humidity, altitude, rainfall,
etc.) are favourable to the development of the parasite and to the sur-
vival of the malaria vector mosquito. The presence of dams may further
increase the incidence of malaria by providing breeding habitats for the
malaria mosquitoes.
To assess the effect of dams on Plasmodium falciparum malaria in-
cidence, a study was conducted in 16 villages surrounding the Gilgel-
Gibe hydroelectric dam reservoir, South-West Ethiopia (Yewhalaw et al.,
2010, 2013). It has been postulated that children living far away from
the dam are less at risk for malaria as compared to children living nearby
(Yewhalaw et al., 2009).
A shared frailty model with time-to-malaria as response, distance to
the dam as main covariate, and village as frailty term has been used to
assess this hypothesis (Yewhalaw et al., 2013; Getachew et al., 2013).
In the shared frailty model, observations within a village have the same
frailty. The village-specific frailty term aims at taking into account the
dependence of observations from the same village. With a shared frailty
term, however, any two children within a village exhibit the same de-
gree of association. In addition, observations from different villages are
assumed to be independent (between-village independence assumption).
Thus, the spatial dependence, i.e. the tendency of observations taken
in close proximity to exhibit positive association, is not explicitly taken
into account be the shared frailty model. As a first step, we focus in
this chapter on modelling spatial dependence between villages.
In the frailty model framework, spatial dependence between obser-
vations can be accounted for by modelling spatial dependence between
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frailties (Diggle & Ribeiro Junior, 2007, Section 4.3.3). In this chapter,
we adopt this strategy to explore spatial dependence in the malaria data.
A review of the relevant literature is presented in Section 6.1. The
spatial frailty model is introduced for the malaria data in Section 6.2.
Section 6.3 provides some insight into how spatial dependence between
frailties induce spatial dependence between survival times. The malaria
data is analysed in Section 6.4. Directions for future developments are
proposed in Section 6.5.
The work in this chapter is ongoing.
6.1
Literature review and outline
Geostatistical methods are mainly developed under the assumption that
the distribution of the outcome variable is normal (Diggle & Ribeiro Ju-
nior, 2007; Littell et al., 2006, Chapter 11). In the setting of survival
analysis, these methods have received scant attention. A few Bayesian
and frequentist approaches have been proposed to model spatial de-
pendence in survival data using the frailty model methodology (see
below). Alternatively, a normal transformation marginal model (no
frailty), whereby the event time is transformed into a normally dis-
tributed random variable, is proposed in Li & Lin (2006).
Henderson et al. (2002) investigate spatial variation in leukemia inci-
dence across districts in North-west England within the Bayesian frame-
work. The model is based on a hierarchical specification. Individual
frailties within district i have a gamma distribution with a district-
specific mean µi. Spatial dependence is then induced by assuming that
the µi’s follow a multivariate normal distribution with unit mean and a
spatially-structured variance-covariance matrix. The model reduces to
the univariate gamma frailty model in the case of no spatial dependence.
Banerjee et al. (2003) consider a cluster-specific random effect with
a conditionally autoregressive prior. That prior distribution incorpo-
rates information about the adjacency of the clusters (the neighbourhood
structure). The model is applied to infant mortality data in Minnesota
counties. Further applications can be found in Banerjee & Carlin (2003),
Diva et al. (2007), Ojiambo & Kang (2013), and Jin & Carlin (2005).
The latter model relies on the position of the clusters (counties) relative
to each other (“lattice approach”). In addition, Banerjee et al. (2003)
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also use the exact geographical locations of the clusters (“geostatistical
approach”) by means of a cluster-specific log frailty term following a
multivariate normal distribution with variance-covariance matrix spec-
ified as a function of distance. The model reduces to the log-normal
shared frailty model in the case of no spatial dependence. Both the
lattice and the geostatistical approaches are also discussed within the
framework of the proportional odds model in Banerjee & Dey (2005)
with an application to breast cancer data in Iowa counties; see also Diva
et al. (2008).
The frequentist counterpart of the geostatistical approach to model
spatial dependence between cluster-specific frailty terms is undertaken in
Li & Ryan (2002). The method relies either on Monte Carlo simulations
or on the Laplace method to approximate the marginal likelihood and
is applied to childhood asthma data in Boston counties.
Based on a somewhat similar approximation as in Li & Ryan (2002),
a two-stage procedure iterating between a weighted estimating equation
to estimate the regression coefficients and a variogram (cf. Section 6.3)
to estimate the variance components is developed in Lin (2012) for a
study of forest decline (tree mortality). It should be noted however
that the use of variograms for formal inference is discouraged (Diggle &
Ribeiro Junior, 2007, Chapter 5).
In this chapter, we consider the frequentist geostatistical approach
using the Laplace method to approximate the marginal likelihood. The
Laplace method for frailty models is implemented in R (coxph(), part of
the survival library) and in SAS (proc phreg) for independent frailties
(McGilchrist, 1993; Therneau et al., 2003). Relaxation of the indepen-
dence assumption between frailties is addressed in Ripatti & Palmgren
(2000). The method has been used in Pankratz et al. (2005) to model
dependent survival times among family members in a large familial co-
hort study of breast cancer (within a family, frailties are different, but
correlated, due to different degrees of genetic association) and is imple-
mented in the coxme() function in R (part of the coxme library). Pos-
sible correlation structures in coxme(), however, are targeted to genetic
applications. In this chapter, as a first step towards modelling spatial
dependence in the malaria data, we model spatial dependence between
villages using the maximum likelihood approach of Ripatti & Palmgren
(2000), similar to Li & Ryan (2002). Extension to spatial dependence
both between villages and between households within a village requires
further work; cf. Section 6.5.
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6.2
Spatial frailty model
To study the risk of malaria around the Gilgel-Gibe dam, a cohort of
children living in villages within a 10 km radius from the dam reservoir
were monitored at weekly intervals over a period of two years (July 2008
– June 2010) and times to malaria were collected. Figure 6.1 is a location
map of the study area. Details of the study design have been previously
published (Yewhalaw et al., 2010, 2013).
In the study area, six periods (three rainy seasons per year and two
study years) can be identified and modelled by a piecewise constant
baseline hazard; h0(t) = λm in period [am, am+1), m = 1, . . . ,M . The
household distance to the dam, calculated as the shortest distance to
the dam shore, is the risk factor of interest. Following Getachew (2013,
Chapter 4), we decompose the household distance to the dam into its
between-village and within-village components. Further, we include a
log frailty term acting at the village level. The model we consider is thus
hij(t) = λm exp(x¯i·βb + dijβw + wi) (6.1)
for t ∈ [am, am+1), where hij(·) is the malaria hazard rate for child j
(j = 1, . . . , ni) of village i (i = 1, . . . , s), x¯i· is the village averaged
distance to the dam (with βb the distance effect at the village level),
and dij = xij − x¯i· is the deviation of the household distance from the
village averaged distance (with βw the distance effect within a village).
The log frailty term of village i, hereafter called random effect, is denoted
by wi.
Note: piecewise constant h0(·) and H0(·)
0 = a1 a2 a3 am am+1 aM−1 aM aM+1 =∞
λm
If t ∈ [am, am+1), then
h0(t) = λm and H0(t) =
(
m−1∑
k=1
λk(ak+1 − ak)
)
+ λm(t− am)
where ∑m−1k=1 λk(ak+1 − ak) is set to 0 if m = 1.
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Figure 6.1: Location map of the study area showing the households
(small circles) surrounding the Gilgel-Gibe hydroelectric dam reservoir.
The big circles indicate the position of the village centres.
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The random effect in (6.1) models the dependence among children
within a village. In order to further model spatial dependence between
villages, i.e. similarity in susceptibility to malaria in adjacent villages
compared to distant villages, we model spatial dependence among ran-
dom effects (Diggle & Ribeiro Junior, 2007, Section 4.3.3). We use the
multivariate normal distribution with mean 0 and variance-covariance
matrix D(θ). Typical in the spatial setting is that covariance is a func-
tion of distance. Accordingly, we assume that D(θ) is an s × s matrix
of form [
D(θ)
]
i1i2
= Cov(wi1 , wi2) = θ1ρ(di1i2 ; θ2)
for some correlation function ρ(·; θ2) of the distance between villages†.
To put it differently, the vector of random effect parameters can be
viewed as a realisation of a stationary Gaussian process {W (x): x ∈
R ⊂ R2} with mean 0, variance θ1, and correlation function ρ(d; θ2) =
Cor
(
W (x),W (x′)
)
, where d = ‖x − x′‖ denotes the Euclidean distance
between the village centre locations x and x′. This type of process is
said to be isotropic in the sense that ρ(·; θ2) is symmetric with respect
to direction (the correlation at any two locations depends solely on the
separation between them).
For the malaria data, we focus on the Gaussian covariance structure
ρ(d; θ2) = exp
{
− (d/θ2)2
}
, θ2 > 0 (6.2)
but other choices (see, e.g., Littell et al., 2006, Section 11.3.1) can be
made (further work).
To fit the spatial frailty model (6.1), we can maximise the marginal
likelihood. The marginal likelihood requires integration over the random
effects. Since closed form integration is not possible in the case of normal
random effects, an approximation is needed. Following Ripatti & Palm-
gren (2000), an analytical approximation of the marginal likelihood can
be obtained by means of Laplacian integration (Goutis & Casella, 1999).
The Laplace approximation of the marginal log-likelihood is given by
`marg(λ,β,θ; Z)
≈ −12 log
(
det
(
D(θ)
))
− 12 log
(
det
(
K(2)(w˜)
))
−K(w˜) (6.3)
†In this chapter, the distance between two villages corresponds to the distance be-
tween the village centres.
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with
K(w) := K(λ,β,w,θ; Z)
= −
[
s∑
i=1
ni∑
j=1
δij
(
log
(
h0(yij)
)
+ x′ijβ + wi
)
−H0(yij) exp(x′ijβ + wi)
]
+ 12w
′D−1(θ)w (6.4)
where w˜ := w˜(λ, β,θ) is such that K(1)(w˜) := dKdw (w˜) = 0 and where
K(2)(·) := d2Kdw dw′ (·). Details are provided in Appendix 6.A. Maximisa-
tion of the (fully parametric) marginal log-likelihood (6.3) can be done
numerically by means of an optimisation routine (e.g., a Newton-type
algorithm).
6.3
Spatial dependence
In the spatial setting, the standard graphical tool to describe spatial
dependence/variability is the semi-variogram. The semi-variogram is
defined as one half the variance of the difference between two realisa-
tions of the underlying geostatistical process. For a stationary isotropic
process Z, the semi-variogram is
γZ (d) =
1
2 Var
(
Z(x)− Z(x′)
)
= Var
(
Z
)
− Cov
(
Z(x), Z(x′)
)
with d = ‖x− x′‖.
A typical semi-variogram is shown in Figure 6.2. The value of the
plateau in the semi-variogram corresponds to the variance of a realisation
and is called the sill in the jargon of geostatistics. The distance at which
the semi-variogram reaches the sill is called the range (if the sill is only
reached asymptotically, then the practical range, defined as the distance
at which the semi-variogram reaches 95% of the sill, is used in practice).
For distances lower than the range, realisations exhibit less variability
than expected due to spatial correlation. As the distance between two
realisations increases, also the semi-variogram increases, indicating less
spatial correlation. For distances greater than the range, realisations are
no longer spatially correlated.
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Figure 6.2: A typical semi-variogram with its main features (sill and
range).
Given x and x′ two village locations equally distant from the dam,
the semi-variograms of the random effect (W ) and frailty (exp(W )) pro-
cesses are
γW (d) = θ1
(
1− ρ(d; θ2)
)
and
γexp(W )(d) = exp(θ1)
[
exp(θ1)− exp
(
θ1ρ(d; θ2)
)]
with d = ‖x − x′‖. See Figure (6.3) for plots of γW (d) and γexp(W )(d)
versus d in the case of the Gaussian correlation structure (6.2) for given
values of θ1 and θ2.
Observations from Figure (6.3) are as follows:
• The degree of unobserved heterogeneity between villages (sill) is
controlled by the parameter θ1.
• The rate of spatial decay (range), i.e. the speed at which the semi-
variogram reaches the sill, is governed by the parameter θ2. Higher
values of θ2 indicate larger ranges of spatial dependence.
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Figure 6.3: Semi-variograms of the random effect (W ) and frailty
(exp(W )) processes in the case of the Gaussian correlation structure.
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In order to provide some insight into how spatial correlation between
random effects induces spatial dependence between survival times and
log survival times, we assume a constant baseline hazard (M = 1).
Given x and x′ two village locations equally distant from the dam, the
semi-variograms of the log survival time (log(T )) and survival time (T )
processes are (for details, see Appendix 6.B)
γlog(T )(d) = E
[
Var
(
log(T ) |W
)]
+ γW (d)
= pi
2
6 + θ1
(
1− ρ(d; θ2)
)
and
γT (d) = E
[
Var
(
T |W
)]
+
[ 1
λ exp(x′β)
]2
γexp(W )(d)
=
[ 1
λ exp(x′β)
]2
exp(θ1)
{
2 exp(θ1)− exp
(
θ1ρ(d; θ2)
)}
with d = ‖x− x′‖. In words:
• The semi-variogram of log(T ) is the same as that of W , except
for an intercept, the so-called nugget effect, here attributed to
variability in outcomes measured at the same location;
• The semi-variogram of T is proportional to that of exp(W ), plus
the corresponding nugget effect.
Explicit from the previous formulas is that θ2 in (6.2) retains its inter-
pretation as a range parameter at the level of the survival times and log
survival times.
6.4
Malaria data analysis
A total of 2039 children from 16 villages (between 123 and 130 children
per village) participated to the malaria study. Children entered the
study on the same day and were monitored at weekly intervals dur-
ing a period of two years (July 2008 – June 2010). For each child
diagnosed with malaria during the study period, the time to the first
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Figure 6.4: Number of cases by time period in the malaria data.
malaria episode (in days) was recorded. The household and village dis-
tances to the dam, as well as the exact household and village locations
(latitude and longitude), are also available. The distance between two
villages, calculated as the distance between the village centres, ranges
from 1.475 km to 23.194 km (1st quartile = 7.306, median = 11.989,
mean = 11.162, 3rd quartile = 14.379). Each of the two study years
is divided into 3 rainy seasons, resulting in 6 intervals for the piece-
wise constant baseline hazard rate (Getachew, 2013, page 28): [1, 151),
[151, 271), [271, 361), [361, 511), [511, 631), [631, 699). A total of 547
malaria cases (≈ 27%) were reported (cf. Figure 6.4). The 1492 children
(≈ 73%) without malaria during the study period were censored at the
last follow-up visit, which is the same for every child (698 days).
Results of fitting the shared frailty model and the spatial frailty
model to the malaria data are shown in Table 6.1. The shared frailty
model is obtained for θ2 → 0 (in practice, θ2 has been fixed to 10−9).
The likelihood ratio statistic (LR = 6.33) indicates that the spatial
frailty model fits significantly better than the shared frailty model, but
estimates and standard errors of the baseline hazard and fixed effects
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Table 6.1: Shared frailty model and spatial frailty model fits to the
malaria data.
shared spatial
parameter estimate std. err. estimate std. err.
λ1 × 104 5.809 1.068 5.903 1.237
λ2 × 104 1.321 0.311 1.341 0.350
λ3 × 104 3.347 0.699 3.395 0.789
λ4 × 104 5.468 1.020 5.544 1.177
λ5 × 104 1.056 0.280 1.070 0.307
λ6 × 104 1.602 0.450 1.622 0.486
βb 0.059 0.067 0.054 0.077
βw −0.122 0.075 −0.118 0.075
θ1 0.314 0.128 0.407 0.304
θ2 8.479 2.472
`marg −4593.420 −4590.255
parameters are similar in both models. In particular, no significant effect
of the distance to the dam is found. Regarding spatial dependence, we
find θˆ2 = 8.479 (se = 2.472), corresponding to a practical range of
approximately 15 km (cf. Figure 6.5).
6.5
Future development
This chapter provides a first step towards modelling spatial dependence
in the malaria data by means of spatially correlated frailties. We have
focused on modelling spatial dependence between villages, i.e. similar-
ity in susceptibility to malaria in adjacent villages compared to distant
villages. In the proposed model, any two children within a village ex-
hibit the same degree of association (shared frailty). In principle, the
method of this chapter can be extended to further model spatial de-
pendence within a village. In that case, the frailty term acts at the
household/child level rather than at the village level. Our preliminary
attempts in that direction have revealed some technical difficulties. The
main difficulty comes with solving the estimating equations for the vari-
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Figure 6.5: Estimate of the semi-variogram of the random effect process
in the malaria data.
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ance components,
∂`marg
∂θq
= −12
[
tr
{[
IN×N −
[
K(2)
]−1
D−1(θ)
]
∂D(θ)
∂θq
D−1(θ)
}
−w˜′D−1(θ)∂D(θ)
∂θq
D−1(θ) w˜
]
= 0
where IN×N denotes the identity matrix of dimension N , with N the
total sample size. Contributing to the difficulty is the need to invert the
N ×N variance-covariance matrix of the random effects (in the malaria
data, this matrix has dimension 2039× 2039). In addition, the Laplace
integration technique used to approximate the marginal likelihood has
been reported to perform poorly with small cluster sizes (Ducrocq &
Casella, 1996; see also Cortiñas Abrahantes & Burzykowski, 2005, and
Rondeau et al., 2008). Further work is thus needed to model spatial
dependence within a village. More discussion is provided at the end the
thesis (closing part).
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Appendix 6.A
Laplace approximation of the marginal likelihood
In the frequentist framework, an estimate of (λ′ β′ θ′)′, with λ the vec-
tor of parameters in h0(·), β the vector of fixed effects parameters, and θ
the vector of frailty parameters, is obtained by maximising the marginal
likelihood of the observed data
Z =
{
(yij , δij ,xij) | j = 1, . . . , ni; i = 1, . . . , s
}
with yij the time to malaria or censoring, whichever comes first, δij the
event indicator identifying a case of malaria (δij = 1) or a right-censored
data (δij = 0), and xij the vector of covariates for child j of village i.
The random effect of village i, wi, is not observed.
To obtain the marginal likelihood of the observed data, the latent
data information w = (w1 . . . ws)′ has to be integrated out from the
joint density of z and w,
Lmarg(λ,β,θ; Z) =
∫ ∞
−∞
· · ·
∫ ∞
−∞
f(Z,w; λ,β,θ) dw
=
∫ ∞
−∞
· · ·
∫ ∞
−∞
f(Z |w; λ,β)f(w; θ) dw
with
f(Z |w; λ,β) =
s∏
i=1
ni∏
j=1
(
h0(yij) exp(x′ijβ + wi)
)δij
exp
{
−H0(yij) exp(x′ijβ + wi)
}
and
f(w; θ) = (2pi)− s/2 det
(
D(θ)
)− 1/2
exp
{
−12w
′D−1(θ)w
}
There exists no closed form expression for Lmarg when the random
effects have a normal distribution. Following Ripatti & Palmgren (2000),
an analytical approximation of the marginal likelihood can be obtained
by means of Laplacian integration (Goutis & Casella, 1999).
Let K(w) := K(λ,β,w,θ; Z) be such that
Lmarg(λ,β,θ; Z)
= (2pi)− s/2 det
(
D(θ)
)− 1/2 ∫ ∞
−∞
· · ·
∫ ∞
−∞
exp
{
−K(w)
}
dw
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The explicit form of K(w) is given in (6.4). Using a Taylor series ex-
pansion of K(·) around w˜, with w˜ such that dKdw (w˜) = 0, we have
K(w) ≈ K(w˜) + 12(w − w˜)
′K(2)(w˜)(w − w˜)
with K(2)(·) := d2Kdw dw′ (·). An approximation of the marginal likelihood
is thus given by
Lmarg(λ,β,θ; Z)
≈ (2pi)− s/2 det
(
D(θ)
)− 1/2
exp
{
−K(w˜)
}
×
∫ ∞
−∞
· · ·
∫ ∞
−∞
exp
{
−12 (w − w˜)
′K(2)(w˜) (w − w˜)
}
dw
= det
(
D(θ)
)− 1/2
det
(
K(2)(w˜)
)− 1/2
exp
{
−K(w˜)
}
where the last equality follows by completing the integrand to recover
the normal density with mean w˜ and covariance matrix [K(2)(w˜)]−1.
Appendix 6.B
Semi-variograms of T and log (T ) for the case M = 1
In this appendix, we work out the semi-variograms of T and log(T ), i.e.
γT (d) =
1
2 Var
(
T (x)− T (x′)
)
and
γlog(T )(d) =
1
2 Var
(
log
(
T (x)
)
− log
(
T (x′)
))
in the case M = 1 (constant baseline hazard) by making use of the
log-linear representation of model (6.1), where d = ‖x−x′‖ denotes the
Euclidean distance between the village centre locations x and x′ equally
distant from the dam.
Log-linear representation of model (6.1) in the case M = 1
The log-linear representation of model (6.1) when M = 1 is of form(
log(Tij) |W = wi
)
= − log(λ)− x′ijβ − wi + Eij (6.5)
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where Eij is a random error term from a Gumbel distribution with
density
f(e) = exp
{
e− exp(e)
}
The mean and the variance of Eij are E(Eij) = −γ and Var(Eij) = pi26 ,
with γ ≈ 0.577 the Euler’s constant. Then, conditional on W = wi, the
survival time Tij is given by(
Tij |W = wi
)
= 1
λ exp(x′ijβ)
exp(−wi) exp(Eij) (6.6)
To see that the log-linear model (6.5) is equivalent to the hazard
model (6.1) (when M = 1), we show that both representations lead to
the same conditional survival function. Starting from (6.5), we have
Pr
(
Tij > t |W = wi
)
= Pr
(
log(Tij) > log(t) |W = wi
)
= Pr
(
Eij > log(t) + log(λ) + x′ijβ + wi
)
= Pr
(
exp(Eij) > λt exp(x′ijβ + wi)
)
= exp
{
−λt exp(x′ijβ + wi)
}
where we have used the fact that exp(Eij) ∼ Exp(1).
Semi-variogram of log (T )
Let Z = log(T ). On the one hand, for two village locations x and x′
equally distant from the dam, we have, using (6.5),
E
(
Z(x)− Z(x′)
∣∣∣W) = W (x′)−W (x)
On the other hand,
Var
(
Z(x)− Z(x′)
∣∣∣W) = 2 Var(Z ∣∣∣W)
Therefore, using the law of total variance, the semi-variogram of Z is
γZ (d)
= 12 Var
(
Z(x)− Z(x′)
)
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= 12 E
[
Var
(
Z(x)− Z(x′)
∣∣∣W)]+ 12 Var
[
E
(
Z(x)− Z(x′)
∣∣∣W)]
= E
[
Var
(
Z
∣∣∣W)]+ γW (d)
with d = ‖x− x′‖.
Note: law of total variance
Var(X) = E
[
Var(X |Y )
]
+ Var
[
E(X |Y )
]
Semi-variogram of T
Let Z = T . On the one hand, for two village locations x and x′ equally
distant from the dam, we have, using (6.6),
E
(
Z(x)− Z(x′)
∣∣∣W) = 1
λ exp(x′β)
[
exp
(
−W (x)
)
− exp
(
−W (x′)
) ]
On the other hand,
Var
(
Z(x)− Z(x′)
∣∣∣W) = 2 Var(Z ∣∣∣W)
Therefore, using the law of total variance, the semi-variogram of Z is
γZ (d)
= 12 Var
(
Z(x)− Z(x′)
)
= 12 E
[
Var
(
Z(x)− Z(x′)
∣∣∣W)]+ 12 Var
[
E
(
Z(x)− Z(x′)
∣∣∣W)]
= E
[
Var
(
Z
∣∣∣W)]+ [ 1
λ exp(x′β)
]2
γexp(W )(d)
with d = ‖x− x′‖.
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Concluding discussion
The main focus of this thesis was on modelling the frailty term in the
frailty model. Specific achievements include a unified framework for
fitting the parametric frailty model with different frailty distributions
and the accompanying R library parfm (Chapter 2), a new diagnostic
plot to evaluate the frailty distribution assumption (Chapter 3), a sim-
ulation study to assess robustness of regression inference against frailty
misspecification (Chapter 4), and a method to test for decreasing clus-
ter heterogeneity in a new time-varying frailty model (Chapter 5). Also
presented is a first step towards modelling spatial dependence in sur-
vival data by means of spatially correlated frailties (Chapter 6). The
discussion below collects concluding remarks, summarises the findings,
and suggests directions for further research.
Implementation of statistical methods, especially model estimation
algorithms, in standard software is an essential step towards practical
applications. It was not until the advent of computers that the paper by
Kaplan & Meier (1958), one of the most cited papers in the entire field of
science (Ryan & Woodall, 2005), began to be widely used among applied
researchers (Garfield, 1989). With present technology, not providing the
necessary tools to put theory into practice is like building a bridge to
nowhere. After all, it is not surprise that number 2 on Donoho’s list of
causal factors for highly cited papers (Donoho, 2002) is “Implement the
method in software, place examples of the software’s use in the paper,
make the software of broad functionality, and give the software away
for free.” The R library parfm is a step in that direction. The parfm
package presently supports four frailty distributions in the parametric
frailty model. Although significant improvements are possible, feedback
from users made it clear that parfm, or at least the parfm methodology,
has filled a void in the realm of frailty models. Nonetheless, further
developments are needed to make parfm of broad functionality and to
open the door to new practical applications. In particular, the inclu-
sion of the PVF frailty distribution should be quite straightforward (as
demonstrated in Chapter 2) and might lead to simple goodness-of-fit
likelihood ratio tests for the frailty distribution (cf. Section 1.5 of the
thesis appendix). To ensure longevity, parfm could be merged with an
existing, well-maintained package (e.g. frailtypack).
The parfm package has been useful as well in the development of a
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diagnostic technique to evaluate the frailty distribution assumption. As
seen in Chapter 4, frailty misspecification does not appear to affect infer-
ence for fixed effects. In contrast, the type of dependence that the frailty
term generates between event times in a cluster is dictated by the choice
of frailty distribution. This is evidenced by the fact that local measures
of dependence (e.g. the cross ratio) take different forms depending on the
frailty distribution assumption (cf. Appendix 3.A). Therefore, diagnos-
tic techniques are particularly relevant to studies where the dependence
structure is of special interest. The study on mastitis infection in dairy
cows used to illustrate the methodology of Chapter 3 is one such exam-
ple. The dependence structure between infection times of the four udder
quarters of a cow provides insight into the risks of cross-contamination
between infected and non-infected udder quarters. For this type of stud-
ies, diagnostic techniques to select the most appropriate frailty distribu-
tion are needed in order to correctly describe the dependence in the data.
Much of the work towards this end focused on comparing an empirical
to a model-based estimate of the cross ratio (Oakes, 1989; Viswanathan
& Manatunga, 2001; Chen & Bandeen-Roche, 2005; Glidden, 2007). As
an alternative, quantile dependence has been used in Chapter 3. The
main motivation for using quantile dependence as a diagnostic tool was
to capture the behaviour of the frailty distribution in the tails. To be
specific, the heaviness of the tails of the frailty distribution has a ma-
jor influence on whether dependence is mostly present between short,
intermediate, or long event times, as is the case with positive stable,
inverse Gaussian, and gamma frailties, respectively. Incidentally, quan-
tile dependence is defined in terms of survival rather than in terms of
hazard, making the non-parametric estimation somewhat easier. For the
mastitis data, the non-parametric estimate suggests that early infections
happen in the same cows (early dependence), a pattern consistent with
the positive stable frailty distribution (cf. Figure 3.5). In essence, the
proposed diagnostic tool parallels the QQ plot. The simulations con-
ducted in Chapter 3 indicate satisfactory performance of the proposed
graphic tool. Nonetheless, more experience is needed to demonstrate
the value of the proposed method in real applications.
Alternatives to diagnostic plots and goodness-of-fit tests for model
selection are information criteria, e.g. the Akaike Information Criterion
(AIC) and the Bayesian Information Criterion (BIC). Modifications of
AIC and BIC for use in survival analysis have been proposed (Liang
et al., 2008; Volinsky & Raftery, 2000). For copula models (the relation-
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ship between copula and frailty models is discussed in Goethals et al.
(2008, 2012)), the use of AIC to select a copula in a list of candidates is
investigated and promoted in Fang et al. (2014). For frailty models, and
more generally for random effects models, the definitions of AIC and
BIC are not unambiguous. What likelihood and penalty term should be
used? This question has been addressed for the selection of random ef-
fects, first in the linear mixed model (Vaida & Blanchard, 2005; Liang &
Zou, 2008; Greven & Kneib, 2010) and then in generalised linear mixed
and frailty models (Donohue et al., 2011). For this purpose, it is argued
that a modified version of the AIC, the conditional Akaike Informa-
tion Criterion (cAIC), should be used. To the best of our knowledge,
the use of cAIC, or of any other information criterion, for the selection
of the random effect/frailty distribution has not been addressed in the
literature. This may be an interesting subject for further research.
A second objective of this work was to ascertain the sensitivity of
regression inference to the choice of frailty distribution. In a particular
application, conclusions regarding the effect of frailty misspecification
can be drawn by fitting the frailty model with different frailty distribu-
tions. For example, different frailty models for breast cancer recurrence
data were applied in dos Santos et al. (1995). The results indicate that
the effect of different frailty distributions on the parameter estimates
and their standard errors was slight. Further insight can be gained from
a simulation study. In a simulation setting, survival data are generated
from the frailty model, with a known frailty distribution and known
model parameters, and robustness properties are derived based on the
parameters in the misspecified frailty model. A simulation study can
be designed to mimic specific study characteristics (number of clusters,
number of observations per cluster, amount of heterogeneity, effect size,
event rate, etc.) and hence allows to evaluate the effect of frailty mis-
specification in a variety of settings. A general approach to generating
survival data to simulate the frailty model is given in the thesis appendix
(Appendix 2). In multicentre clinical trial data, there is increasing em-
pirical evidence that inferences about the treatment effect are robust
against frailty misspecification. The use of the frailty model could then
be further promoted in that context (cf. Chapter 4, supplementing re-
sults from Glidden & Vittinghoff (2004)). It should be noted that the
case of cluster-randomised trials (Murray et al., 2004), i.e. trials in which
the centres rather than the individual patients are randomly allocated
to intervention and control groups, has not been covered in Chapter 4
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and might deserve a specific simulation study.
Up until that point, the frailty term was assumed to remain un-
changed over time. Also of interest in some applications are frailty
models with time-varying frailties. Time-varying frailties enable, e.g.,
to model changes in lifestyle (Gottard et al., 2012) or serial dependence
between recurrent event times (cf. the references given in Section 5.1).
In Chapter 5, time-varying frailties were used to investigate decreas-
ing heterogeneity between bone marrow transplant centres in a study of
chronic myeloid leukemia. We have approached that problem by using a
transformation towards the linear mixed effects model (cf. Section 5.2).
To be specific, we have modelled the logarithm of the cumulative haz-
ard as a linear mixed effects model with a time-varying, random centre
effect. The foundation of the proposed transformation model, for which
the theoretical properties are studied in the case of time-varying fixed ef-
fects (no frailty) in Teodorescu et al. (2010), involves the non-parametric
estimation of the pseudo-responses and subsequent use of linear mixed
model techniques (Grigoletto & Akritas, 1999). In the leukemia data,
we have found that heterogeneity declines over time, with almost no
heterogeneity after roughly nine months from transplantation (cf. Fig-
ure 5.1). The statistical significance of the decrease has been assessed
by means of a generic trend test procedure described in Rice & Gaines
(1994a,b) (cf. Section 5.2.5). An alternative test would be one of the
tests for the homogeneity of a set of variances against ordered alter-
natives studied in Fujino (1979). The ability to use standard software
is a strength of the proposed method. However, this practical benefit
comes at a cost in terms of applicability due to the preliminary esti-
mation of the pseudo-responses which requires substantial information
(number of events) within each cluster. For the leukemia data, small
transplant centres have been discarded from the analysis. Further, con-
tinuous covariates represent an additional difficulty for the estimation
of the pseudo-responses (kernel-based estimation; cf. López-de-Ullibarri
et al. (2012)). For the leukemia data analysis, the covariate information
has been summarised into a binary prognostic index (“low-risk” versus
“high-risk”). Overall, I think that although the proposed method pro-
vides a practical way to get an insight on cluster heterogeneity and its
time dependency in certain situations, e.g. a treatment outcome study
with few centres of large sizes, a method with broader applicability is
desirable.
The malaria data has been the source of inspiration for Chapter 6.
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Specific for the malaria data is that dependence between event times is
a function of the distance between subjects (spatial dependence). Our
particular interest has been to determine the extent of spatial depen-
dence in the malaria study area. In the last decade, this type of prob-
lem has prompted the development of geostatistical methods for survival
data (cf. the references given in Section 6.1). A natural way to incor-
porate spatial dependence between event times is to use the multivari-
ate log-normal frailty distribution with a spatially structured variance-
covariance matrix (Diggle & Ribeiro Junior, 2007, Section 4.3.3). Within
that framework, we have modelled, as a first step, spatial dependence
at the cluster (village) level. This is essentially the approach taken in
Li & Ryan (2002). Application to the malaria data indicates significant
spatial dependence in the study area, with a range of spatial dependence
estimated at 15 km. It must be noted, however, that some of the villages
are rather large. The assumption that the frailty term takes the same
value within a village, rather than different, spatially dependent values,
is therefore called into question. Further, the village boundaries are
quite vague and somewhat arbitrary. Extension to spatial dependence
at the household level, with one random effect per household/child, en-
tails a number of technical difficulties and requires further work. First,
the practical implementation is more involved due to the large number
of random effects. Contributing to the difficulty is the need to invert the
variance-covariance matrix of the random effects in the marginal likeli-
hood (6.3) and in its gradient. Further, it has been reported that the
Laplace approximation used to obtain the marginal log-likelihood (6.3)
(cf. Appendix 6.A) performs poorly for small cluster sizes (Ducrocq &
Casella, 1996; see also Cortiñas Abrahantes & Burzykowski, 2005, and
Rondeau et al., 2008). This suggests that another method is needed to fit
the model with spatial dependence at the household level (see, e.g., Sec-
tion 6.1). In addition, the household-specific random effect models un-
observed heterogeneity between households (overdispersion), i.e. greater
variability than expected (Hougaard, 1995; Wienke, 2010, Chapter 3),
and the fact that overdispersion is needed for the presence of spatial
dependence is a drawback of the model. In that respect, the accelerated
failure time model with spatially dependent error terms might deserve
some attention (see Klein et al. (1999) for one avenue to be pursued).
Closing 140
Future development
A further field of application of frailty models concerns the analysis of
recurrent event times. Recurrent event analysis covers situations where
the event of interest may occur multiple times per subject. Examples
from medical research are chronic asthma attacks, repeated infections
after surgery, cancer relapses, etc. Typical for recurrent event data is
that outcomes from the same subject are dependent (recurrences are
clustered within subjects). Further, for some diseases, recurrences are
associated with an increased risk of death. Joint frailty models have been
proposed to take into account the within-subject dependence as well as
the dependent censoring of recurrent event times by death (Liu et al.,
2004). A joint frailty model consists of a frailty model for each of the two
endpoints (recurrence and death). On the one hand, the within-subject
dependence is modelled by an individual-specific frailty term U in the
hazard function of the recurrent event times. On the other hand, the
dependence between the recurrent event times and the survival time is
usually modelled by including Uγ in the hazard function of the survival
time (thus linking the two models), with γ ∈ R an unknown parameter.
Owing to the parameter γ, the common frailty term is allowed to have
different effects on the two hazard rates. To fit the joint frailty model,
an EM algorithm with a Metropolis-Hastings E-step is developed in
Liu et al. (2004) and in Huang & Liu (2007). Alternatively, maximum
penalised likelihood estimation is used in Rondeau et al. (2007). The
latter approach is implemented in the R library frailtypack (Rondeau
et al., 2012).
Application of joint frailty modelling of recurrent event times and
time to death in cancer research allows to assess whether the treatment
has an effect on the recurrent/death rate and to quantify the association
between recurrence and death (Rondeau, 2010; Mazroui et al., 2012;
see also Rondeau et al., 2011 and Taylor & Wang, 2002). In addition,
joint frailty models have the potential to determine the extent to which
the treatment effect on survival is mediated through the recurrences.
Thus, joint frailty modelling may well have a role to play in evaluating
the use of recurrences as a surrogate endpoint in cancer clinical trials
(De Gruttola et al., 2001).
A further application of joint frailty models is to dynamically predict
the risk of death for an individual patient, given the patient’s history of
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recurrences (Mauguen et al., 2013). Using ideas in Faucett et al. (2002),
these predicted probabilities of death could then be used to recover part
of the information that is lost due to censoring via multiple imputation.
By treating the recurrences as auxiliary responses, efficiency of the treat-
ment effect estimate on the primary response (survival) is expected to
be gained.
Overall, it is proposed to evaluate whether recurrences are appropri-
ate for use both as a surrogate endpoint for survival and as auxiliary
responses to improve the efficiency of the treatment effect on survival.

Appendix

1Frailty distributions
1.1
Gamma
notation & parameter space
U ∼ Gam(θ), θ > 0
density
f(u) = (
1/θ)1/θ u(1/θ)−1 exp (−(1/θ)u)
Γ(1/θ)
R syntax
dgamma(x=u, shape=1/theta, scale=theta)
[library: stats]
Laplace transform
L(x) = (1 + θx)− 1/θ
mean & variance
E(U) = 1 and Var(U) = θ
Kendall’s τ
θ
θ + 2
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Figure 1.1: Gamma densities.
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1.2
Inverse Gaussian
notation & parameter space
U ∼ IG(θ), θ > 0
density
f(u) = 1√
2piθ
u−3/2 exp
(
− 12θu (u− 1)
2
)
R syntax
dinvgauss(x=u, mu=1, lambda=1/theta)
[library: statmod]
Laplace transform
L(x) = exp
{1
θ
(
1−√1 + 2θx
)}
mean & variance
E(U) = 1 and Var(U) = θ
Kendall’s τ
τ = 12 −
1
θ
+ 2
θ2
exp
(2
θ
)∫ ∞
2/θ
exp(−x)
x
dx
Note: τ < 1/2
Since ∫ ∞
2/θ
exp(−x)
x
dx < θ2
∫ ∞
2/θ
exp(−x) dx = θ2 exp
(
−2
θ
)
it follows that τ < 1/2.
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Figure 1.2: Inverse Gaussian densities.
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1.3
Positive stable
notation & parameter space
U ∼ PS(θ), θ ∈ (0, 1)
density
f(u) = − 1
piu
∞∑
k=1

Γ
(
k(1− θ) + 1
)
k! sin
(
(1− θ)kpi
) (
−uθ−1
)k
R syntax†
dstable(x=u, alpha=1-theta, beta=1, gamma=g(theta), delta=0, pm=1)
[library: stabledist]
Laplace transform
L(x) = exp
(
−x1−θ
)
mean & variance
E(U) =∞ and Var(U) =∞
Kendall’s τ
τ = θ
†Note: the gamma argument of dstable()
gamma =
∣∣∣1− i tan(pi2 (1− θ))∣∣∣− 11−θ = [1 + tan2 (pi2 (1− θ))]− 12(1−θ)
(≈ θ in a neighbourhood of 1/2)
g <− function(theta)
{
i <− complex(real=0, imaginary=1)
abs(1 − i * tan(pi / 2 * (1 − theta)))^(−1 / (1 − theta))
}
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Figure 1.3: Positive stable densities.
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1.4
Log-normal
notation & parameter space
U ∼ LN(θ), θ > 0
density
f(u) = 1√
2piθ
1
u
exp
(
− 12θ
(
log(u)
)2)
R syntax
dlnorm(x=u, meanlog=0, sdlog=sqrt(theta))
[library: stats]
Laplace transform
No explicit formula exists.
mean & variance
E(U) = exp
(
θ
2
)
and Var(U) = exp(θ)
(
exp(θ)− 1
)
Kendall’s τ
No explicit formula exists.
Note: relation with the normal distribution
Let W ∼ N(µ, θ). Then U = exp(W ) has a two-parameter log-
normal distribution with
E(U) = exp
(
µ+ θ2
)
and Var(U) = exp(2µ+ θ)
(
exp(θ)− 1
)
The standard assumption, adopted here, is to take E(W ) = µ = 0.
Note in this case that E(U) 6= 1. Alternatively, one can take µ =
−θ/2 so that E(U) = 1.
In terms of W , the frailty model is written as hij(t) = h0(t) exp(wi + x′ijβ).
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Figure 1.4: Log-normal densities.
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1.5
Power variance function
The family of power variance function (PVF) distributions contains the
inverse Gaussian as a particular case, as well as the gamma and the
positive stable as limiting cases.
The Laplace transform of U ∼ PVF(µ, θ, ν) is†
L(x) = exp
{
ν
θ(1− ν)
[
1−
(
1 + θµx
ν
)1−ν]}
with µ > 0, θ > 0, and ν ∈ (0, 1).
The mean and the variance of U are
E(U) = µ and Var(U) = θµ2
The typical choice to ensure identifiability of the parameters in the frailty
model is µ = 1.
For µ = 1 and ν → 1, the gamma frailty distribution Gam(θ) is
obtained. For µ = 1 and ν = 1/2, the inverse Gaussian frailty distribu-
tion IG(θ) is obtained. To obtain the positive stable frailty distribution
PS(ν), we need to take
θ = ν
(1− ν)1/ν µ
(1/ν)−1
and to let µ go to infinity. For details, see Duchateau & Janssen (2008,
Section 4.5.1).
†The relation with the parametrisation used in Hougaard (2000, Section A.3.4) is as
follows:
αh = 1 − ν θh = ν
θµ
δh = µ1−ν
(
ν
θ
)ν
where the subscript “H” stands for “Hougaard”.
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1.6
Compound Poisson
A compound Poisson (CP) random variable can be constructed as the
sum of a Poisson distributed number k of independent random variables,
U =
{
X1 + · · ·+Xk if k > 0
0 if k = 0
As Pr(U = 0) is positive, the compound Poisson frailty distribution
provides a way to model a cure fraction in the population (Price &
Manatunga, 2001; Moger et al., 2004).
Interestingly, when the Xi’s have a two-parameter gamma distribu-
tion, the compound Poisson distribution has the same Laplace trans-
form as the PVF, except that ν > 1 (Duchateau & Janssen, 2008, Sec-
tion 4.6.1).
2Generation of survival times to simulate
the frailty model
Together with graphs, Monte Carlo simulations are among the most
helpful tools to develop or confirm intuition by repeating some exper-
iment using (pseudo-)random samples†. The essence of Monte Carlo
simulations is that we know and control the data generating mechanism.
2.1
The inverse probability method
To generate clustered event times from the frailty model, we can use
the inverse probability method (Bender et al., 2005): if V is uniform on
(0, 1) and if S(· |x, u) is the conditional survival function derived from
the frailty model, i.e.
S(t |x, u) = exp
(
−H0(t)u exp(x′β)
)
then it is a fact that the random variable
T = S−1(V |x, u) = H−10
(
− log(V )
u exp(x′β)
)
has survival function S(· |x, u). This result is known as “the inverse
probability integral transformation”. Therefore, to generate a survival
time T ∼ S(· |x, u) given the covariate vector and the frailty term, it suf-
fices to draw v from V ∼ U(0, 1) and to make the inverse transformation
t = S−1(v |x, u).
†For a nice illustration of how repeating the “Monty Hall game show problem” has
convinced the most reluctant readers of the “Ask Marilyn” column in Parade Mag-
azine, see the discussion at marilynvossavant.com/game-show-problem.
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2.2
Examples
Example 1 [Weibull baseline hazard]
Let h0(t) = λρtρ−1 with shape ρ > 0 and scale λ > 0. Then H0(t) =
λtρ and H−10 (t) = ( tλ)
1/ρ. Following the inverse probability method, a
realisation of T ∼ S(· |x, u) is obtained by computing
t =
(
− log(v)
λu exp(x′β)
)1/ρ
with v a uniform variate on (0, 1). Using results on transformations
of random variables, one may notice that T has a conditional Weibull
distribution (given x and u) with shape ρ and scale λu exp(x′β).
Example 2 [piecewise constant baseline hazard]
Let h0(t) = λm if t ∈ [am, am+1), with 0 = a0 < a1 < · · · < aM <
aM+1 =∞. Then, for t ∈ [am, am+1),
H0(t) =
(
m−1∑
k=1
λk(ak+1 − ak)
)
+ λm(t− am)
and
H−10 (t) = am +
1
λm
[
t−
(
m−1∑
k=1
λk(ak+1 − ak)
)]
where we set ∑m−1k=1 λk(ak+1 − ak) to zero if m = 1. Following the
inverse probability method, a realisation of T ∼ S(· |x, u) is obtained
by computing
t = am − 1
λm
[
log(v)
u exp(x′β) +
(
m−1∑
k=1
λk(ak+1 − ak)
)]
with v a uniform variate on (0, 1). To determinem in the above formula,
note that if am ≤ t < am+1, then
exp
{
−u exp(x′β)
(
m∑
k=1
λk(ak+1 − ak)
)}
< v
≤ exp
{
−u exp(x′β)
(
m−1∑
k=1
λk(ak+1 − ak)
)}
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2.3
Sample code in R
# baseline hazard: Weibull
# frailty distribution: gamma
# s = number of clusters
# n = (n_1 ... n_s) with n_i the nb of obs in cluster i
# lambda = scale parameter in h0()
# rho = shape parameter in h0()
# beta = fixed effect parameter
# theta = frailty parameter
# rateC = rate parameter of the exponential dist of C
simulWeibGam <− function(s, n, lambda, rho, beta, theta, rateC)
{
# total number of observations
N <− sum(n)
# cluster identification number
cluster <− factor(rep(1:s, times=n))
# gamma frailties
u <− rep(rgamma(n=s, shape=1/theta, scale=theta), times=n)
# covariate −−> N Bernoulli trials
x <− sample(x=c(0, 1), size=N, replace=TRUE, prob=c(0.5, 0.5))
# Weibull latent event times
v <− runif(n=N)
Tlat <− (− log(v) / (lambda * u * exp(x * beta)))^(1 / rho)
# censoring times
C <− rexp(n=N, rate=rateC)
# follow−up times and event indicators
time <− pmin(Tlat, C)
status <− as.numeric(Tlat <= C)
# data set
data.frame(id=1:N,
cluster=cluster,
time=time,
status=status,
x=x)
}

3Bootstrap in the frailty model
The broad aim of the bootstrap is to simulate the data generating mecha-
nism in order to create replicate data sets. In its non-parametric version,
the empirical distribution function is used to resample from the original
data. Alternatively, the model-based bootstrap uses a fitted model. In
the hypothesis testing framework, a model-based bootstrap can be used
to determine the finite-sample null distribution of the test statistic by
resampling the data under H0.
Bootstrap methods for non-clustered survival data are described in
Davison & Hinkley (1997, Section 3.5 and Section 7.3). In the presence
of clustering, a model-based resampling plan, based on the frailty model,
is developed in Massonnet et al. (2006). Some details are given below.
The non-parametric bootstrap for clustered survival data simply consists
in randomly selecting clusters with replacement (Therneau & Grambsch,
2000, page 249; Ren et al., 2010).
3.1
Model-based bootstrap
To resample the event times, we need a model-based estimate of the
conditional event time survival function. The conditional event time
survival function derived from the frailty model is
Sˆij(t) = exp
{
−Hˆ0(t)ui exp(x′ijβˆ)
}
where Hˆ0(t) and βˆ are the estimates obtained by fitting the frailty model
to the original data. In the semi-parametric setting, we take the Breslow
estimator for Hˆ0(·), i.e.
Hˆ0(t) =
∑
y˜(`)≤t
d`∑
i,j∈R(y˜(`)) ui exp(x
′
ijβˆ)
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with y˜(1) < · · · < y˜(r) the ordered distinct event times, d` the number of
events at time y˜(`), and R(y˜(`)) the risk set at y˜(`).
To resample the censoring times, we need an estimate of the cen-
soring time survival function. An estimator of the censoring time sur-
vival function can be obtained via the Kaplan-Meier estimator (cf. Sec-
tion 1.2.4) by interchanging the role of the event times and the censoring
times.
Algorithm
For individual j of cluster i (j = 1, . . . , ni; i = 1, . . . , s),
1. Sample u?i from the frailty distribution (where an estimate θˆ of
the frailty parameter is obtained by fitting the frailty model to the
original data);
2. Generate t?ij from the model-based estimate of the conditional
event time survival function (with ui = u?i );
3. If δij = 0, then set c?ij = yij ; otherwise, generate c?ij from the
estimate of the censoring time survival function given that Cij >
yij , i.e. Gˆ(·)/Gˆ(yij);
4. Set y?ij = min(t?ij , c?ij) and δ?ij = I(t?ij ≤ c?ij).
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